Top

Jeffrey H Lee, MD, MPH

Department of Gastroenterology Hepatology and Nutrition, Division of Internal Medicine

About Dr. Jeffrey H Lee

Jeffrey H Lee, MD, is currently a Professor of Medicine in the Department of Gastroenterology of the M D Anderson Cancer Center in Houston, Texas, USA. Prior to joining MD Anderson Cancer Center in 2003, he served as faculty at Yale University School of Medicine after completing a fellowship in Advanced Therapeutic Endoscopy at Harvard Medical School where he also completed his education in public health. Since he joined MD Anderson Cancer Center, he has been working tirelessly to bring new techniques and technology to provide care for our patients and teach colleagues and fellows. He served as the Medical Director of Endoscopy and Director of Advanced Endoscopy until March 2025 and served as the President for Texas Society of Gastroenterology and Endoscopy in 2018-2020.

Nationally, he served as the Chair of the ERCP Committee in the American Society for Gastrointestinal Endoscopy and as a member on the International Relations Committee in the American College of Gastroenterology and Annual Scientific Program Committee of Digestive Disease Week. He currently serves as a member on the Educations Affairs Committee in the American College of Gastroenterology and a member of DDW Hands-on Training Committee of American Society for Gastrointestinal Endoscopy.

Dr. Lee’s main academic interests include diagnosing and staging of various gastrointestinal malignancies, gallbladder cancer, biliary and pancreatic diseases, and state-of-the art advances in the use of endoscopy as a therapeutic tool, such as endoscopic ultrasound (EUS)-guided gastrojejunostomy, EUS-guided endoscopic retrograde cholangiopancreatography, and EUS-guided gallbladder drainage.

Widely published with more than 250 articles in peer-reviewed journals, Dr. Lee has written articles on topics, such as endoscopic ultrasound and fine-needle aspiration in unexplained bile duct strictures, pancreatic endosonography after Bilroth II gastrectomy, use of metallic biliary stents in resectable pancreatic cancer, EUS and ERCP in one session. He has also lectured extensively at the national (Digestive Disease Week Annual Meetings and American College of Gastroenterology Annual Scientific Meeting) and international meetings, professional association meetings, academic forums, hospital grand rounds, and live-endoscopy courses.

Dual/Joint/Adjunct Appointment

Professor, Department of Gastroenterology, Hepatology, & Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas

Education & Training

Postgraduate Training

null-1999

Advanced Endoscopy Fellow, Advanced Endoscopy, Gastroenterology, Harvard University, Boston, MA

Experience & Service

Administrative Appointments/Responsibilities

Director, Advanced Endoscopy Fellowship, Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2016 - Present

Institutional Committee Activities

Committee member, Educations Affairs Committee of the American College of Gastroenterology, 2024 - Present

Director, DDW ERCP Hands-on Training 2025, DDW Hands-on Education Committee, 2024 - Present

Honors & Awards

	Perfect score nationally, Consumer Assessment of Healthcare Providers and Systems
	Top 1% nationally in patient care, Consumer Assessment of Healthcare Providers and Systems

Professional Memberships

Texas Society of Gasteroenterology and Endoscopy

2008 - Present

Selected Publications

Peer-Reviewed Articles

Al Nakshabandi A, Ali FS, Albustami I, Hwang H, Qiao W, Johnston NC, Shaikh AS, Coronel E, Ge PS, Ross W, Weston B, Lee JH. Biliary drainage in hilar and perihilar cholangiocarcinoma: 25-year experience at a tertiary cancer center. Gastrointest Endosc 99(6):938-949.e15, 2024. e-Pub 2024. PMID: 38092128.
Jain AJ, Lendoire M, Boyev A, Newhook TE, Tzeng CD, Tran Cao HS, Coronel E, Lee SS, Hu ZI, Javle M, Lee JH, Vauthey JN, Chun YS. Revisiting the Malignant Masquerade at the Liver Hilum: Have We Made Progress?. Ann Surg Oncol 31(5):3062-3068, 2024. e-Pub 2024. PMID: 38282027.
Vassilakopoulou, M, Chen, HC, Wang, X, Harada, K, Iwatsuki, M, Das, P, Blum Murphy, M, Matamoros Jr, A, Sagebiel, T, Devine, CE, Thomas, I, Sanders, E, Shanbhag, N, Rogers, JE, Lee, JH, Weston, B, Bhutani, M, Hofstetter, WL, Nguyen, Q, Badgwell, BD, Ajani, JA. Localized Gastroesophageal Adenocarcinoma in the Elderly. Oncology (Switzerland) 101(3):153-158, 2023. e-Pub 2023. PMID: 36412619.
Low, DJ, Yu, AC, Liu, C, Shaukat Ali, F, Al Nakshabandi, A, Coronel, E, Ge, PS, Lee, JH. Endoscopic retrograde cholangiopancreatography in patients with pancreaticoduodenectomy with and without the use of a rigidizing overtube. International Journal of Gastrointestinal Intervention 12(3):115-122, 2023. e-Pub 2023.
Lee, JH. Advances in the diagnosis and treatment of cholangiocarcinoma over the past decade. International Journal of Gastrointestinal Intervention 12:S16, 2023. e-Pub 2023.
Emelogu IK, Campbell DR, Lanke G, Yu AC, Nogueras-Gonzalez G, Lum P, Coronel E, Ge PS, Ross WA, Weston BR, Katz MH, Lee JH. A decade's experience of managing suspected pancreatic adenocarcinoma at a tertiary cancer center. Ann Gastroenterol 36(1):81-86, 2023. e-Pub 2023. PMID: 36593816.
Kang Y, Deng J, Ling J, Li X, Chiang YJ, Koay EJ, Wang H, Burks JK, Chiao PJ, Hurd MW, Bhutani MS, Lee JH, Weston BR, Maitra A, Ikoma N, Tzeng CD, Lee JE, DePinho RA, Wolff RA, Pant S, McAllister F, Katz MH, Fleming JB, Kim MP. 3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma. J Clin Invest 132(24), 2022. e-Pub 2022. PMID: 36282600.
Kumar S, Bahdi F, Emelogu IK, Yu AC, Coronel M, Ge PS, Coronel E, Ajani JA, Weston B, Lynch P, Ross WA, Lee JH. How much progress have we made?: a 20-year experience regarding esophageal stents for the palliation of malignant dysphagia. Dis Esophagus 35(6), 2022. e-Pub 2022. PMID: 34937091.
Gan Q, Roy-Chowdhuri S, Duose DY, Stewart JM, Coronel E, Bhutani MS, Lee JH, Weston B, Ge PS, Ross WA, Maitra A. Adequacy evaluation and use of pancreatic adenocarcinoma specimens for next-generation sequencing acquired by endoscopic ultrasound-guided FNA and FNB. Cancer Cytopathol 130(4):275-283, 2022. e-Pub 2022. PMID: 34905283.
Song S, Chen Q, Li Y, Lei G, Scott A, Huo L, Li CY, Estrella JS, Correa A, Pizzi MP, Ma L, Jin J, Liu B, Wang Y, Xiao L, Hofstetter WL, Lee JH, Weston B, Bhutani M, Shanbhag N, Johnson RL, Gan B, Wei S, Ajani JA. Targeting cancer stem cells with a pan-BCL-2 inhibitor in preclinical and clinical settings in patients with gastroesophageal carcinoma. Gut 70(12):2238-2248, 2021. e-Pub 2021. PMID: 33487592.
Hao D, He S, Harada K, Pizzi MP, Lu Y, Guan P, Chen L, Wang R, Zhang S, Sewastjanow-Silva M, Abdelhakeem A, Shanbhag N, Bhutani M, Han G, Lee JH, Zhao S, Weston B, Blum Murphy M, Waters R, Estrella JS, Roy-Chowdhuri S, Gan Q, Lee JS, Peng G, Hanash SM, Calin GA, Song X, Zhang J, Song S, Wang L, Ajani JA. Integrated genomic profiling and modelling for risk stratification in patients with advanced oesophagogastric adenocarcinoma. Gut 70(11):2055-2065, 2021. e-Pub 2021. PMID: 33334899.
Weston BR, Patel JM, Pande M, Lum PJ, Ross WA, Raju GS, Lynch PM, Coronel E, Ge PS, Lee JH. Efficacy of uncovered colonic stents for extrinsic versus intrinsic malignant large bowel obstruction. Surg Endosc 35(8):4511-4519, 2021. e-Pub 2021. PMID: 32909212.
Harada K, Hwang H, Wang X, Abdelhakeem A, Iwatsuki M, Blum Murphy MA, Maru DM, Weston B, Lee JH, Rogers JE, Thomas I, Shanbhag N, Zhao M, Bhutani MS, Nguyen QN, Swisher SG, Ikoma N, Badgwell BD, Hofstetter WL, Ajani JA. Frequency and Implications of Paratracheal Lymph Node Metastases in Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma. Ann Surg 273(4):751-757, 2021. e-Pub 2021. PMID: 31188215.
Hou T, Stewart JM, Lee JH, Gan Q. Solid Tumor Metastases to the Pancreas Diagnosed Using Fine-Needle Aspiration. Am J Clin Pathol 154(5):692-699, 2020. e-Pub 2020. PMID: 32651950.
Harada K, Patnana M, Wang X, Iwatsuki M, Murphy MAB, Zhao M, Das P, Minsky BD, Weston B, Lee JH, Bhutani MS, Estrella JS, Shanbhag N, Ikoma N, Badgwell BD, Ajani JA. Low metabolic activity in primary gastric adenocarcinoma is associated with resistance to chemoradiation and the presence of signet ring cells. Surg Today 50(10):1223-1231, 2020. e-Pub 2020. PMID: 32409870.
Cazacu IM, Singh BS, Luzuriaga Chavez AA, Koduru P, Ejaz S, Weston BR, Ross WA, Lee JH, Roy-Chowdhuri S, Bhutani MS. EUS and EUS-guided FNA/core biopsies in the evaluation of subepithelial lesions of the lower gastrointestinal tract: 10-year experience. Endosc Ultrasound 9(5):329-336, 2020. e-Pub 2020. PMID: 32913150.
Harada K, Hwang H, Wang X, Abdelhakeem A, Iwatsuki M, Murphy MAB, Maru DM, Weston B, Lee JH, Rogers JE, Trail A, Shanbhag N, Zhao M, Bhutani MS, Nguyen QN, Swisher SG, Ikoma N, Das P, Hofstetter WL, Badgwell BD, Ajani JA. Brain metastases in patients with upper gastrointestinal cancer is associated with proximally located adenocarcinoma and lymph node metastases. Gastric Cancer 23(5):904-912, 2020. e-Pub 2020. PMID: 32347396.
Harada K, Wu CC, Wang X, Mizrak Kaya D, Amlashi FG, Iwatsuki M, Blum Murphy MA, Maru DM, Weston B, Lee JH, Rogers JE, Thomas I, Shanbhag N, Bhutani MS, Hofstetter WL, Nguyen QN, Ajani JA. Total Lesion Glycolysis Assessment Identifies a Patient Fraction With a High Cure Rate Among Esophageal Adenocarcinoma Patients Treated With Definitive Chemoradiation. Ann Surg 272(2):311-318, 2020. e-Pub 2020. PMID: 32675544.
Angsuwatcharakon P, Ahmed O, Lynch PM, Lum P, Gonzalez GN, Weston B, Coronel E, Katz MHG, Folloder J, Lee JH. Management of ampullary adenomas in familial adenomatous polyposis syndrome: 16 years of experience from a tertiary cancer center. Gastrointest Endosc 92(2):323-330, 2020. e-Pub 2020. PMID: 32145286.
Song S, Li Y, Xu Y, Ma L, Pool Pizzi M, Jin J, Scott AW, Huo L, Wang Y, Lee JH, Bhutani MS, Weston B, Shanbhag ND, Johnson RL, Ajani JA. Targeting Hippo coactivator YAP1 through BET bromodomain inhibition in esophageal adenocarcinoma. Mol Oncol 14(6):1410-1426, 2020. e-Pub 2020. PMID: 32175692.
Lopez A, Harada K, Chen HC, Bhutani MS, Weston B, Lee JH, Maru DM, Chin FW, Rogers JE, Thomas I, Amlashi FG, Blum-Murphy MA, Rice DC, Zhao M, Hofstetter WL, Nguyen Q, Ajani JA. Taxane-based or platinum-based combination chemotherapy given concurrently with radiation followed by surgery resulting in high cure rates in esophageal cancer patients. Medicine (Baltimore) 99(9):e19295, 2020. e-Pub 2020. PMID: 32118743.
Cazacu IM, Luzuriaga Chavez AA, Mendoza TR, Qiao W, Singh BS, Bokhari RH, Saftoiu A, Lee JH, Weston B, Stroehlein JR, Kim MP, G Katz MH, Maitra A, McAllister F, Bhutani MS. Quality of life impact of EUS in patients at risk for developing pancreatic cancer. Endosc Ultrasound 9(1):53-58, 2020. e-Pub 2020. PMID: 31552914.
Mizrak Kaya D, Nogueras Gonzalez GM, Harada K, Blum Murphy MA, Lee JH, Bhutani MS, Weston B, Thomas I, Rogers JE, Das P, Badgwell BD, Ajani JA. Efficacy of Three-Drug Induction Chemotherapy Followed by Preoperative Chemoradiation in Patients with Localized Gastric Adenocarcinoma. Oncology 98(8):542-548, 2020. e-Pub 2020. PMID: 32434189.
Chen D, Menon H, Verma V, Seyedin SN, Ajani JA, Hofstetter WL, Nguyen QN, Chang JY, Gomez DR, Amini A, Swisher SG, Blum MA, Younes AI, Barsoumian HB, Erasmus JJ, Lee JH, Bhutani MS, Hess KR, Minsky BD, Welsh JW. Results of a Phase 1/2 Trial of Chemoradiotherapy With Simultaneous Integrated Boost of Radiotherapy Dose in Unresectable Locally Advanced Esophageal Cancer. JAMA Oncol 5(11):1597-1604, 2019. e-Pub 2019. PMID: 31529018.
Xu Y, Li Y, Jin J, Han G, Sun C, Pizzi MP, Huo L, Scott A, Wang Y, Ma L, Lee JH, Bhutani MS, Weston B, Vellano C, Yang L, Lin C, Kim Y, MacLeod AR, Wang L, Wang Z, Song S, Ajani JA. LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma. Mol Cancer 18(1):141, 2019. e-Pub 2019. PMID: 31601234.
Lee JH, Emelogu I, Kukreja K, Ali FS, Nogueras-Gonzalez G, Lum P, Coronel E, Ross W, Raju GS, Lynch P, Thirumurthi S, Stroehlein J, Wang Y, You YN, Weston B. Safety and efficacy of metal stents for malignant colonic obstruction in patients treated with bevacizumab. Gastrointest Endosc 90(1):116-124, 2019. e-Pub 2019. PMID: 30797835.
Abu-Sbeih H, Ali FS, Coronel E, Chen HC, Wang X, Lum P, Shuttlesworth G, Bhutani MS, Raju GS, Lee JH, Stroehlein JR, Ross WA, Wang Y. Safety of endoscopy in cancer patients with thrombocytopenia and neutropenia. Gastrointest Endosc 89(5):937-949.e2, 2019. e-Pub 2019. PMID: 30550744.
Gulhati P, Prakash L, Katz MHG, Wang X, Javle M, Shroff R, Fogelman D, Lee JE, Tzeng CD, Lee JH, Weston B, Tamm E, Bhosale P, Koay EJ, Maitra A, Wang H, Wolff RA, Varadhachary GR. First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma. Ann Surg Oncol 26(2):619-627, 2019. e-Pub 2019. PMID: 30324485.
Cassani LS, Chouhan J, Chan C, Lanke G, Chen HC, Wang X, Weston B, Ross WA, Raju GS, Lee JH. Biliary Decompression in Perihilar Cholangiocarcinoma Improves Survival: A Single-Center Retrospective Analysis. Dig Dis Sci 64(2):561-569, 2019. e-Pub 2019. PMID: 30238201.
Koay EJ, Katz MHG, Wang H, Wang X, Prakash L, Javle M, Shroff R, Fogelman D, Avila S, Zaid M, Elganainy D, Lee Y, Crane CH, Krishnan S, Das P, Fleming JB, Lee JE, Tamm EP, Bhosale P, Lee JH, Weston B, Maitra A, Wolff RA, Varadhachary GR. Computed Tomography-Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for Borderline Resectable Pancreatic Cancer. JCO Precis Oncol 3, 2019. e-Pub 2019. PMID: 32914036.
Xi M, Hallemeier CL, Merrell KW, Liao Z, Murphy MAB, Ho L, Hofstetter WL, Mehran R, Lee JH, Bhutani MS, Weston B, Maru DM, Komaki R, Ajani JA, Lin SH. Recurrence Risk Stratification After Preoperative Chemoradiation of Esophageal Adenocarcinoma. Ann Surg 268(2):289-295, 2018. e-Pub 2018. PMID: 28628563.
Mizrak Kaya D, Nogueras-Gonzales GM, Harada K, Amlashi FG, Thomas I, Rogers JE, Bhutani MS, Lee JH, Weston B, Minsky BD, Estrella JS, Blum Murphy MA, Matamoros A Jr, Devine CE, Das P, Badgwell BD, Ajani JA. Potentially curable gastric adenocarcinoma treated without surgery. Eur J Cancer 98:23-29, 2018. e-Pub 2018. PMID: 29859338.
DaVee T, Coronel E, Papafragkakis C, Thaiudom S, Lanke G, Chakinala RC, Nogueras Gonzalez GM, Bhutani MS, Ross WA, Weston BR, Lee JH. Pancreatic cancer screening in high-risk individuals with germline genetic mutations. Gastrointest Endosc 87(6):1443-1450, 2018. e-Pub 2018. PMID: 29309780.
Oh SC, Sohn BH, Cheong JH, Kim SB, Lee JE, Park KC, Lee SH, Park JL, Park YY, Lee HS, Jang HJ, Park ES, Kim SC, Heo J, Chu IS, Jang YJ, Mok YJ, Jung W, Kim BH, Kim A, Cho JY, Lim JY, Hayashi Y, Song S, Elimova E, Estralla JS, Lee JH, Bhutani MS, Lu Y, Liu W, Lee J, Kang WK, Kim S, Noh SH, Mills GB, Kim SY, Ajani JA, Lee JS. Clinical and genomic landscape of gastric cancer with a mesenchymal phenotype. Nat Commun 9(1):1777, 2018. e-Pub 2018. PMID: 29725014.
Shimodaira Y, Slack RS, Harada K, Chen HC, Sagebiel T, Bhutani MS, Lee JH, Weston B, Elimova E, Lin Q, Amlashi FG, Mizrak Kaya D, Blum MA, Roth JA, Swisher SG, Skinner HD, Hofstetter WL, Rogers JE, Mares J, Thomas I, Maru DM, Komaki R, Walsh G, Ajani JA. Influence of induction chemotherapy in trimodality therapy-eligible oesophageal cancer patients: secondary analysis of a randomised trial. Br J Cancer 118(3):331-337, 2018. e-Pub 2018. PMID: 29235564.
Harada K, Wang X, Shimodaira Y, Sagebiel T, Bhutani MS, Lee JH, Weston B, Elimova E, Lin Q, Amlashi FG, Mizrak Kaya D, Lopez A, Blum Murphy MA, Roth JA, Swisher SG, Skinner HD, Hofstetter WL, Rogers JE, Thomas I, Maru DM, Komaki R, Walsh G, Ajani JA. Early Metabolic Change after Induction Chemotherapy Predicts Histologic Response and Prognosis in Patients with Esophageal Cancer: Secondary Analysis of a Randomized Trial. Target Oncol 13(1):99-106, 2018. e-Pub 2018. PMID: 29218623.
Amlashi FG, Wang X, Davila RE, Maru DM, Bhutani MS, Lee JH, Weston BR, Mizrak Kaya D, Vassilakopoulou M, Harada K, Blum Murphy MA, Rice DC, Hofstetter WL, Davila M, Nguyen QN, Ajani JA. Barrett's Esophagus after Bimodality Therapy in Patients with Esophageal Adenocarcinoma. Oncology 95(2):81-90, 2018. e-Pub 2018. PMID: 29843157.
Ikoma N, Lee JH, Bhutani MS, Ross WA, Weston B, Chiang YJ, Blum MA, Sagebiel T, Devine CE, Matamoros A Jr, Fournier K, Mansfield P, Ajani JA, Badgwell BD. Preoperative accuracy of gastric cancer staging in patient selection for preoperative therapy: race may affect accuracy of endoscopic ultrasonography. J Gastrointest Oncol 8(6):1009-1017, 2017. e-Pub 2017. PMID: 29299361.
Kirtane T, Cassani L, Davis D 2nd, Lee JH. Pancreatic cystic neoplasms in real-time EUS. VideoGIE 2(12):334-335, 2017. e-Pub 2017. PMID: 29916454.
Xi M, Xu C, Liao Z, Chang JY, Gomez DR, Jeter M, Cox JD, Komaki R, Mehran R, Blum MA, Hofstetter WL, Maru DM, Bhutani MS, Lee JH, Weston B, Ajani JA, Lin SH. Comparative Outcomes After Definitive Chemoradiotherapy Using Proton Beam Therapy Versus Intensity Modulated Radiation Therapy for Esophageal Cancer: A Retrospective, Single-Institutional Analysis. Int J Radiat Oncol Biol Phys 99(3):667-676, 2017. e-Pub 2017. PMID: 29280461.
Blum Murphy M, Xiao L, Patel VR, Maru DM, Correa AM, G Amlashi F, Liao Z, Komaki R, Lin SH, Skinner HD, Vaporciyan A, Walsh GL, Swisher SG, Sepesi B, Lee JH, Bhutani MS, Weston B, Hofstetter WL, Ajani JA. Pathological complete response in patients with esophageal cancer after the trimodality approach: The association with baseline variables and survival-The University of Texas MD Anderson Cancer Center experience. Cancer 123(21):4106-4113, 2017. e-Pub 2017. PMID: 28885712.
Xi M, Xu C, Liao Z, Hofstetter WL, Blum Murphy M, Maru DM, Bhutani MS, Lee JH, Weston B, Komaki R, Lin SH. The impact of histology on recurrence patterns in esophageal cancer treated with definitive chemoradiotherapy. Radiother Oncol 124(2):318-324, 2017. e-Pub 2017. PMID: 28687396.
Mizrak Kaya D, Dong X, Nogueras-Gonzalez GM, Xu Y, Estrella JS, Harada K, Lopez A, Amlashi FG, Hofstetter WL, Maru DM, Nguyen QN, Lee JH, Weston B, Bhutani MS, Erasmus JJ, Thomas I, Rogers JE, Song S, Ajani JA. Post-trimodality expression levels of metadherin (MTDH) as a prognostic biomarker for esophageal adenocarcinoma patients. Med Oncol 34(8):135, 2017. e-Pub 2017. PMID: 28685276.
Weston BR, Ross WA, Bhutani MS, Lee JH, Pande M, Sholl AB, Krishnamurthy S. Prospective randomized comparison of a 22G core needle using standard versus capillary suction for EUS-guided sampling of solid pancreatic masses. Endosc Int Open 5(6):E505-E512, 2017. e-Pub 2017. PMID: 28596983.
Thirumurthi S, Raju GS, Pande M, Ruiz J, Carlson R, Hagan KB, Lee JH, Ross WA. Does deep sedation with propofol affect adenoma detection rates in average risk screening colonoscopy exams?. World J Gastrointest Endosc 9(4):177-182, 2017. e-Pub 2017. PMID: 28465784.
Cassani LS, Lanke G, Chen HC, Wang X, Lynch P, Lee JH. Comparison of nonampullary duodenal adenomas in patients with familial adenomatous polyposis versus patients with sporadic adenomas. Gastrointest Endosc 85(4):803-812, 2017. e-Pub 2017. PMID: 27530072.
Cloyd JM, Katz MH, Prakash L, Varadhachary GR, Wolff RA, Shroff RT, Javle M, Fogelman D, Overman M, Crane CH, Koay EJ, Das P, Krishnan S, Minsky BD, Lee JH, Bhutani MS, Weston B, Ross W, Bhosale P, Tamm EP, Wang H, Maitra A, Kim MP, Aloia TA, Vauthey JN, Fleming JB, Abbruzzese JL, Pisters PW, Evans DB, Lee JE. Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience. J Gastrointest Surg 21(1):164-174, 2017. e-Pub 2017. PMID: 27778257.
Mizrak Kaya D, Wang X, Harada K, Blum Murphy MA, Das P, Minsky BD, Estrella JS, Lin Q, Amlashi FG, Lee JH, Weston B, Bhutani MS, Matamoros A Jr, Sagebiel T, Wu CC, Rogers JE, Thomas I, Maru DM, Skinner HD, Badgwell BD, Hofstetter WL, Ajani JA. 101 Long-Term Survivors Who Had Metastatic Gastroesophageal Cancer and Received Local Consolidative Therapy. Oncology 93(4):243-248, 2017. e-Pub 2017. PMID: 28683449.
Raju GS, Lum PJ, Ross WA, Thirumurthi S, Miller E, Lynch PM, Lee JH, Bhutani MS, Shafi MA, Weston BR, Pande M, Bresalier RS, Rashid A, Mishra L, Davila ML, Stroehlein JR. Outcome of EMR as an alternative to surgery in patients with complex colon polyps. Gastrointest Endosc 84(2):315-25, 2016. e-Pub 2016. PMID: 26859866.
Krishna SG, Bhattacharya A, Li F, Ross WA, Ladha H, Porter K, Atiq M, Bhutani MS, Lee JH. Diagnostic Differentiation of Pancreatic Neuroendocrine Tumor From Other Neoplastic Solid Pancreatic Lesions During Endoscopic Ultrasound-Guided Fine-Needle Aspiration. Pancreas 45(3):394-400, 2016. e-Pub 2016. PMID: 26418912.
Sudo K, Wang X, Xiao L, Wadhwa R, Shiozaki H, Elimova E, Rice DC, Lee JH, Weston B, Bhutani MS, Hiremath A, Charalampakis N, Komaki R, Blum MA, Swisher SG, Maru DM, Skinner HD, Garris JL, Rogers JE, Hofstetter WL, Ajani JA. A Nomogram to Predict Distant Metastases After Multimodality Therapy for Patients With Localized Esophageal Cancer. J Natl Compr Canc Netw 14(2):173-9, 2016. e-Pub 2016. PMID: 26850487.
Shiozaki H, Elimova E, Slack RS, Chen HC, Staerkel GA, Sneige N, Shimodaira Y, Sagebiel T, Lee JH, Bhutani MS, Das P, Mansfield PF, Estrella JS, Badgwell BD, Ajani JA. Prognosis of gastric adenocarcinoma patients with various burdens of peritoneal metastases. J Surg Oncol 113(1):29-35, 2016. e-Pub 2016. PMID: 26603684.
Charalampakis N, Nogueras Gonzalez GM, Elimova E, Wadhwa R, Shiozaki H, Shimodaira Y, Blum MA, Rogers JE, Harada K, Matamoros A Jr, Sagebiel T, Das P, Minsky BD, Lee JH, Weston B, Bhutani MS, Estrella JS, Badgwell BD, Ajani JA. The Proportion of Signet Ring Cell Component in Patients with Localized Gastric Adenocarcinoma Correlates with the Degree of Response to Pre-Operative Chemoradiation. Oncology 90(5):239-47, 2016. e-Pub 2016. PMID: 27046280.
Shiozaki H, Slack RS, Chen HC, Elimova E, Planjery V, Charalampakis N, Wadhwa R, Shimodaira Y, Skinner H, Lee JH, Weston B, Bhutani MS, Blum-Murphy M, Rogers JE, Maru DM, Matamoros A Jr, Sagebiel T, Estrella JS, Das P, Hofstetter WL, Mares JE, Mizrak Kaya D, Harada K, Lin Q, Minsky BD, Badgwell BD, Ajani JA. Metastatic Gastroesophageal Adenocarcinoma Patients Treated with Systemic Therapy Followed by Consolidative Local Therapy: A Nomogram Associated with Long-Term Survivors. Oncology 91(1):55-60, 2016. e-Pub 2016. PMID: 27120436.
Shin EJ, Topazian M, Goggins MG, Syngal S, Saltzman JR, Lee JH, Farrell JJ, Canto MI. Linear-array EUS improves detection of pancreatic lesions in high-risk individuals: a randomized tandem study. Gastrointest Endosc 82(5):812-8, 2015. e-Pub 2015. PMID: 25930097.
Krishna SG, Bhattacharya A, Ross WA, Ladha H, Porter K, Bhutani MS, Lee JH. Pretest prediction and diagnosis of metastatic lesions to the pancreas by endoscopic ultrasound-guided fine needle aspiration. J Gastroenterol Hepatol 30(10):1552-60, 2015. e-Pub 2015. PMID: 25867963.
Raju GS, Lum PJ, Slack RS, Thirumurthi S, Lynch PM, Miller E, Weston BR, Davila ML, Bhutani MS, Shafi MA, Bresalier RS, Dekovich AA, Lee JH, Guha S, Pande M, Blechacz B, Rashid A, Routbort M, Shuttlesworth G, Mishra L, Stroehlein JR, Ross WA. Natural language processing as an alternative to manual reporting of colonoscopy quality metrics. Gastrointest Endosc 82(3):512-9, 2015. e-Pub 2015. PMID: 25910665.
Bektas M, Krishna SG, Ross WA, Weston B, Katz MH, Fleming JB, Lee JH, Bhutani MS. Prevalence of extra-pancreatic cysts in patients with cystic pancreatic lesions detected by endoscopic ultrasound. Endosc Ultrasound 4(3):219-24, 2015. e-Pub 2015. PMID: 26374580.
Eshleman JR, Norris AL, Sadakari Y, Debeljak M, Borges M, Harrington C, Lin E, Brant A, Barkley T, Almario JA, Topazian M, Farrell J, Syngal S, Lee JH, Yu J, Hruban RH, Kanda M, Canto MI, Goggins M. KRAS and guanine nucleotide-binding protein mutations in pancreatic juice collected from the duodenum of patients at high risk for neoplasia undergoing endoscopic ultrasound. Clin Gastroenterol Hepatol 13(5):963-9.e4, 2015. e-Pub 2015. PMID: 25481712.
Ross WA, Thirumurthi S, Lynch PM, Rashid A, Pande M, Shafi MA, Lee JH, Raju GS. Detection rates of premalignant polyps during screening colonoscopy: time to revise quality standards?. Gastrointest Endosc 81(3):567-74, 2015. e-Pub 2015. PMID: 25583558.
Krishna SG, Li F, Bhattacharya A, Ladha H, Porter K, Singh A, Ross WA, Bhutani MS, Lee JH. Differentiation of pancreatic ductal adenocarcinoma from other neoplastic solid pancreatic lesions: a tertiary oncology center experience. Gastrointest Endosc 81(2):370-9, 2015. e-Pub 2015. PMID: 25442085.
Charalampakis N, Xiao L, Elimova E, Wadhwa R, Shiozaki H, Shimodaira Y, Blum MA, Planjery V, Rogers JE, Matamoros A Jr, Sagebiel T, Das P, Lee JH, Bhutani MS, Weston B, Estrella JS, Badgwell BD, Ajani JA. Initial Standardized Uptake Value of Positron Emission Tomography Influences the Prognosis of Patients with Localized Gastric Adenocarcinoma Treated Preoperatively. Oncology 89(6):305-10, 2015. e-Pub 2015. PMID: 26393501.
Shiozaki H, Slack R, Sudo K, Elimova E, Wadhwa R, Chen HC, Skinner HD, Komaki R, Lee JH, Weston B, Bhutani MS, Blum MA, Rogers JE, Maru DM, Hofstetter WL, Ajani JA. Geographic distribution of regional metastatic nodes affects the outcome of trimodality-eligible patients with esophageal adenocarcinoma. Oncology 88(6):332-6, 2015. e-Pub 2015. PMID: 25765098.
Neishaboori N, Wadhwa R, Nogueras-Gonzalez GM, Elimova E, Shiozaki H, Sudo K, Charalampakis N, Hiremath A, Lee JH, Bhutani MS, Weston B, Blum MA, Rogers JE, Garris JL, Rice DC, Komaki R, Swisher SG, Skinner HD, Hofstetter WL, Ajani JA. Distribution of Resistant Esophageal Adenocarcinoma in the Resected Specimens of Clinical Stage III Patients after Chemoradiation: Its Clinical Implications. Oncology 89(2):65-9, 2015. e-Pub 2015. PMID: 25765719.
Skinner HD, Lee JH, Bhutani MS, Weston B, Hofstetter W, Komaki R, Shiozaki H, Wadhwa R, Sudo K, Elimova E, Song S, Ye Y, Huang M, Ajani J, Wu X. A validated miRNA profile predicts response to therapy in esophageal adenocarcinoma. Cancer 120(23):3635-41, 2014. e-Pub 2014. PMID: 25091571.
Sudo K, Xiao L, Wadhwa R, Shiozaki H, Elimova E, Taketa T, Blum MA, Lee JH, Bhutani MS, Weston B, Ross WA, Komaki R, Rice DC, Swisher SG, Hofstetter WL, Maru DM, Skinner HD, Ajani JA. Importance of surveillance and success of salvage strategies after definitive chemoradiation in patients with esophageal cancer. J Clin Oncol 32(30):3400-5, 2014. e-Pub 2014. PMID: 25225435.
Krishna SG, Rao BB, Thirumurthi S, Lee JH, Ramireddy S, Guindani M, Ross WA. Safety of endoscopic interventions in patients with thrombocytopenia. Gastrointest Endosc 80(3):425-34, 2014. e-Pub 2014. PMID: 24721520.
Song S, Ajani JA, Honjo S, Maru DM, Chen Q, Scott AW, Heallen TR, Xiao L, Hofstetter WL, Weston B, Lee JH, Wadhwa R, Sudo K, Stroehlein JR, Martin JF, Hung MC, Johnson RL. Hippo coactivator YAP1 upregulates SOX9 and endows esophageal cancer cells with stem-like properties. Cancer Res 74(15):4170-82, 2014. e-Pub 2014. PMID: 24906622.
Cuellar SL, Carter BW, Macapinlac HA, Ajani JA, Komaki R, Welsh JW, Lee JH, Swisher SG, Correa AM, Erasmus JJ, Hofstetter WL. Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role?. J Thorac Oncol 9(8):1202-6, 2014. e-Pub 2014. PMID: 25157774.
Taketa T, Sudo K, Correa AM, Wadhwa R, Shiozaki H, Elimova E, Campagna MC, Blum MA, Skinner HD, Komaki RU, Lee JH, Bhutani MS, Weston BR, Rice DC, Swisher SG, Maru DM, Hofstetter WL, Ajani JA. Post-chemoradiation surgical pathology stage can customize the surveillance strategy in patients with esophageal adenocarcinoma. J Natl Compr Canc Netw 12(8):1139-44, 2014. e-Pub 2014. PMID: 25099446.
Amini A, Ajani J, Komaki R, Allen PK, Minsky BD, Blum M, Xiao L, Suzuki A, Hofstetter W, Swisher S, Gomez D, Liao Z, Lee JH, Bhutani MS, Welsh JW. Factors associated with local-regional failure after definitive chemoradiation for locally advanced esophageal cancer. Ann Surg Oncol 21(1):306-14, 2014. e-Pub 2014. PMID: 24197760.
Sudo K, Taketa T, Correa AM, Campagna MC, Wadhwa R, Blum MA, Komaki R, Lee JH, Bhutani MS, Weston B, Skinner HD, Maru DM, Rice DC, Swisher SG, Hofstetter WL, Ajani JA. Locoregional failure rate after preoperative chemoradiation of esophageal adenocarcinoma and the outcomes of salvage strategies. J Clin Oncol 31(34):4306-10, 2013. e-Pub 2013. PMID: 24145339.
Francis AM, Sepesi B, Correa AM, Blum MA, Erasmus JJ, Lee JH, Maru DM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Welsh JW, Swisher SG, Hofstetter WL. The influence of histopathologic tumor viability on long-term survival and recurrence rates following neoadjuvant therapy for esophageal adenocarcinoma. Ann Surg 258(3):500-7, 2013. e-Pub 2013. PMID: 24022442.
Lee JH, Krishna SG, Singh A, Ladha HS, Slack RS, Ramireddy S, Raju GS, Davila M, Ross WA. Comparison of the utility of covered metal stents versus uncovered metal stents in the management of malignant biliary strictures in 749 patients. Gastrointest Endosc 78(2):312-24, 2013. e-Pub 2013. PMID: 23591331.
Wang W, Shpaner A, Krishna SG, Ross WA, Bhutani MS, Tamm EP, Raju GS, Xiao L, Wolff RA, Fleming JB, Lee JH. Use of EUS-FNA in diagnosing pancreatic neoplasm without a definitive mass on CT. Gastrointest Endosc 78(1):73-80, 2013. e-Pub 2013. PMID: 23523302.
Suzuki R, Lee JH, Krishna SG, Ramireddy S, Qiao W, Weston B, Ross WA, Bhutani MS. Repeat endoscopic ultrasound-guided fine needle aspiration for solid pancreatic lesions at a tertiary referral center will alter the initial inconclusive result. J Gastrointestin Liver Dis 22(2):183-7, 2013. e-Pub 2013. PMID: 23799217.
Cheedella NK, Suzuki A, Xiao L, Hofstetter WL, Maru DM, Taketa T, Sudo K, Blum MA, Lin SH, Welch J, Lee JH, Bhutani MS, Rice DC, Vaporciyan AA, Swisher SG, Ajani JA. Association between clinical complete response and pathological complete response after preoperative chemoradiation in patients with gastroesophageal cancer: analysis in a large cohort. Ann Oncol 24(5):1262-6, 2013. e-Pub 2013. PMID: 23247658.
Atiq M, Bhutani MS, Ross WA, Raju GS, Gong Y, Tamm EP, Javle M, Wang X, Lee JH. Role of endoscopic ultrasonography in evaluation of metastatic lesions to the pancreas: a tertiary cancer center experience. Pancreas 42(3):516-23, 2013. e-Pub 2013. PMID: 23211369.
Saftoiu A, Bhutani MS, Vilmann P, Surlin V, Uthamanthil RK, Lee JH, Bektas M, Singh H, lonut D, Gheonea, Pactrascu S, Gupta V, Katz MH, Fleming JB. Feasibility study of EUS-NOTES as a novel approach for pancreatic cancer staging and therapy: an international collaborative study. Hepatogastroenterology 60(121):180-6, 2013. e-Pub 2013. PMID: 22776721.
Murphy MA, Taketa T, Sudo K, Lee JH, Ajani JA. Surveillance for esophageal cancer: does it make sense?. J Natl Compr Canc Netw 10(12):1590-2, 2012. e-Pub 2012. PMID: 23221793.
Ajani JA, Correa AM, Hofstetter WL, Rice DC, Blum MA, Suzuki A, Taketa T, Welsh J, Lin SH, Lee JH, Bhutani MS, Ross WA, Maru DM, Macapinlac HA, Erasmus J, Komaki R, Mehran RJ, Vaporciyan AA, Swisher SG. Clinical parameters model for predicting pathologic complete response following preoperative chemoradiation in patients with esophageal cancer. Ann Oncol 23(10):2638-2642, 2012. e-Pub 2012. PMID: 22831985.
Marks JL, Hofstetter W, Correa AM, Mehran RJ, Rice D, Roth J, Walsh G, Vaporciyan A, Erasmus J, Chang J, Maru D, Lee JH, Lee J, Ajani JA, Swisher SG. Salvage esophagectomy after failed definitive chemoradiation for esophageal adenocarcinoma. Ann Thorac Surg 94(4):1126-32; discussion 1132-3, 2012. e-Pub 2012. PMID: 22921233.
Hayashi Y, Correa AM, Hofstetter WL, Vaporciyan AA, Mehran RJ, Rice DC, Suzuki A, Lee JH, Bhutani MS, Welsh J, Lin SH, Maru DM, Swisher SG, Ajani JA. Patients with high body mass index tend to have lower stage of esophageal carcinoma at diagnosis. Dis Esophagus 25(7):614-22, 2012. e-Pub 2012. PMID: 22150920.
Amini A, Xiao L, Allen PK, Suzuki A, Hayashi Y, Liao Z, Hofstetter W, Crane C, Komaki R, Bhutani MS, Lee JH, Ajani JA, Welsh J. Celiac node failure patterns after definitive chemoradiation for esophageal cancer in the modern era. Int J Radiat Oncol Biol Phys 83(2):e231-9, 2012. e-Pub 2012. PMID: 22436793.
Kumar NB, Vadaparampil ST, Mahajan N, Lilienfeld HS, Lee JH, Laronga C, Hakam A, Hein JJ, Egan KM, Arun B, Pal T. Metformin- A Promising Agent for Chemoprevention in BRCA1 Carriers. Hereditary Genet 1(2), 2012. e-Pub 2012. PMID: 26097796.
Atiq M, Bhutani MS, Bektas M, Lee JE, Gong Y, Tamm EP, Shah CP, Ross WA, Yao J, Raju GS, Wang X, Lee JH. EUS-FNA for pancreatic neuroendocrine tumors: a tertiary cancer center experience. Dig Dis Sci 57(3):791-800, 2012. e-Pub 2012. PMID: 21964743.
Jaganmohan S, Lynch PM, Raju RP, Ross WA, Lee JE, Raju GS, Bhutani MS, Fleming JB, Lee JH. Endoscopic management of duodenal adenomas in familial adenomatous polyposis--a single-center experience. Dig Dis Sci 57(3):732-7, 2012. e-Pub 2012. PMID: 21960285.
Taketa T, Correa AM, Suzuki A, Blum MA, Chien P, Lee JH, Welsh J, Lin SH, Maru DM, Erasmus JJ, Bhutani MS, Weston B, Rice DC, Vaporciyan AA, Hofstetter WL, Swisher SG, Ajani JA. Outcome of trimodality-eligible esophagogastric cancer patients who declined surgery after preoperative chemoradiation. Oncology 83(5):300-4, 2012. e-Pub 2012. PMID: 22964903.
Suzuki A, Xiao L, Taketa T, Blum MA, Matamoros A Jr, Chien PL, Mansfield PF, Fournier KF, Weston B, Lee JH, Bhutani MS, Estrella JS, Delclos ME, Krishnan S, Das P, Ajani JA. Localized gastric cancer treated with chemoradation without surgery: UTMD Anderson Cancer Center experience. Oncology 82(6):347-51, 2012. e-Pub 2012. PMID: 22677933.
Suzuki A, Xiao L, Hayashi Y, Blum MA, Welsh JW, Lin SH, Lee JH, Bhutani MS, Weston B, Maru DM, Rice DC, Swisher SG, Hofstetter WL, Erasmus J, Ajani JA. Nomograms for prognostication of outcome in patients with esophageal and gastroesophageal carcinoma undergoing definitive chemoradiotherapy. Oncology 82(2):108-13, 2012. e-Pub 2012. PMID: 22328056.
Singal AK, Ross WA, Guturu P, Varadhachary GR, Javle M, Jaganmohan SR, Raju RP, Fleming JB, Raju GS, Kuo YF, Lee JH. Self-expanding metal stents for biliary drainage in patients with resectable pancreatic cancer: single-center experience with 79 cases. Dig Dis Sci 56(12):3678-84, 2011. e-Pub 2011. PMID: 21750930.
Suzuki A, Xiao L, Hayashi Y, Macapinlac HA, Welsh J, Lin SH, Lee JH, Bhutani MS, Maru DM, Hofstetter WL, Swisher SG, Ajani JA. Prognostic significance of baseline positron emission tomography and importance of clinical complete response in patients with esophageal or gastroesophageal junction cancer treated with definitive chemoradiotherapy. Cancer 117(21):4823-33, 2011. e-Pub 2011. PMID: 21456015.
Kim HN, Alousi AM, Lee JH, Qiao W, Xiao L, Ross WA. Role of ERCP in patients after hematopoietic stem cell transplantation. Gastrointest Endosc 74(4):817-24, 2011. e-Pub 2011. PMID: 21802682.
Krishna SG, Lee JH. Endosonography in solid and cystic pancreatic tumors. J Interv Gastroenterol 1(4):193-201, 2011. e-Pub 2011. PMID: 22586537.
Estrella JS, Hofstetter WL, Correa AM, Swisher SG, Ajani JA, Lee JH, Bhutani MS, Abraham SC, Rashid A, Maru DM. Duplicated muscularis mucosae invasion has similar risk of lymph node metastasis and recurrence-free survival as intramucosal esophageal adenocarcinoma. Am J Surg Pathol 35(7):1045-53, 2011. e-Pub 2011. PMID: 21602659.
Raju RP, Jaganmohan SR, Ross WA, Davila ML, Javle M, Raju GS, Lee JH. Optimum palliation of inoperable hilar cholangiocarcinoma: comparative assessment of the efficacy of plastic and self-expanding metal stents. Dig Dis Sci 56(5):1557-64, 2011. e-Pub 2011. PMID: 21222156.
Lee JH, Ross WA, Davila R, Chang G, Lin E, Dekovich A, Davila M. Self-expandable metal stents (SEMS) can serve as a bridge to surgery or as a definitive therapy in patients with an advanced stage of cancer: clinical experience of a tertiary cancer center. Dig Dis Sci 55(12):3530-6, 2010. e-Pub 2010. PMID: 20721627.
Leung KK, Ross WA, Evans D, Fleming J, Lin E, Tamm EP, Lee JH. Pancreatic cystic neoplasm: the role of cyst morphology, cyst fluid analysis, and expectant management. Ann Surg Oncol 16(10):2818-24, 2009. e-Pub 2009. PMID: 19536601.
Ross WA, Alkassab F, Lynch PM, Ayers GD, Ajani J, Lee JH, Bismar M. Evolving role of self-expanding metal stents in the treatment of malignant dysphagia and fistulas. Gastrointest Endosc 65(1):70-6, 2007. e-Pub 2007. PMID: 17185082.
Rohatgi PR, Correa AM, Swisher SG, Wu TT, Liao Z, Komaki R, Walsh GL, Vaporciyan AA, Lee JH, Rice DC, Roth JA, Ajani JA. Gender-based analysis of esophageal cancer patients undergoing preoperative chemoradiation: differences in presentation and therapy outcome. Dis Esophagus 19(3):152-7, 2006. e-Pub 2006. PMID: 16722991.
Wasan SM, Ross WA, Staerkel GA, Lee JH. Use of expandable metallic biliary stents in resectable pancreatic cancer. Am J Gastroenterol 100(9):2056-61, 2005. e-Pub 2005. PMID: 16128952.
Lee JH, Topazian M. Pancreatic endosonography after Billroth II gastrectomy. Endoscopy 36(11):972-5, 2004. e-Pub 2004. PMID: 15520914.
Lee JH, Salem R, Aslanian H, Chacho M, Topazian M. Endoscopic ultrasound and fine-needle aspiration of unexplained bile duct strictures. Am J Gastroenterol 99(6):1069-73, 2004. e-Pub 2004. PMID: 15180727.

Editorials

Lee JH. How far have we come in the design of biliary stents: Are biodegradable stents ready for prime time?. Gastrointest Endosc 92(2):412-414, 2020. PMID: 32703372.

Abstracts

Ali FS, Nehme F, Nogueras-González, GM, Low D, Nakshabandim A, Lum P, Ge PS, Ross, WA, Coronel E, Lee JH, Weston BR. Esophageal stent fixation and migration risk of fully covered self-expanding metal stents: a tertiary cancer center experience. DDW 2023 59(11):2035, 2023. e-Pub 2023. PMID: 38004084.
Lee JH, Johnston N, Al-Bustami IS, Low DJ, Ross WA, Coronel E, Ge P, Weston BR. The outcomes of ampullary adenomas in observation without intervention, endoscopic papillectomy, and surgical intervention, 2023. e-Pub 2023.
Low DJ, Al-Bustami IS, Ross WA, Weston BR, Coronel E, Nakshabandi AA, Ge P, Lee JH. Analysis of pancreatic cystic lesions and factors assoiciated with pancreas adenocarcinoma development from 2000-2023 at a tertiary care oncology center, 2023. e-Pub 2023.
Low DJ, Al-Bustami IS, Weston BR, Ge P, Coronel E, Ross WA, Nakshabandi AA, Hame PS, Lee JH. The use of lumen apposing metal stent in non-peripancreatic fluid collections at a tertiary care oncology center between 2017 and 2022, 2023. e-Pub 2023.
Nakshabandi AA, Ali F, Al-Bustami IS, Johnston N, Shaikh A, Low DJ, Ross WA, Weston BR, Ge P, Coronel E, Lee JH. Biliary drainage in perihilar cholangiocarcinoma – 25 year experience at a large US tertiary cancer center, 2023. e-Pub 2023.
Low DJ, Nakshabandi A, Liu C, Ali FS, Ge PS, Coronel E, Br W, Ross WA, Lee J. Analysis of technical failure in post-pancreaticoduodenectomy patients undergoing endoscopic retrograde cholangiopancreatography. DDW 2023 97(6), 2023. e-Pub 2023.
Low DJ, Nakshabandi A, Ali FS, Liu C, Ge PS, Coronel E, Weston BR, Ross WA, Lee J. Endoscopic retrograde cholangiopancreatography in patients with pancreaticoduodenectomy with and without rigidizing overtube. DDW 2023 6(1):66, 2023. e-Pub 2023.
Low D, Nakshabandi A, Liu, Cynthia, Ali FS, Lee J, G PS, Weston BR, Coronel E. Complex endoscopic retrograde cholangiopancreatography in patients with pancreaticoduodenectomy using rigidizing overtube. DDW 2023, 2023. e-Pub 2023.
Zhao M, Prakash RL, Hill VF, Chiang YJ, Lee JH, Ross WA, Coronel E, Ge P, Weston B, Maxwell JE, Newhook TE, Tzeng, Ikoma N, Lee JE, Katz MHG, Bhutani MS, Kim MP. Cyst Fluid Glucose Levels are Superior to Cyst Fluid CEA levels in the Identification of Mucinous Pancreatic Cysts. SSAT/DDW 2022, 2022. e-Pub 2022.
Nehme F, Lee JH. Predictors of malignancy for patients with inconclusive endoscopic ultrasound-guided fine needle aspiration of solid pancreatic masses. ASGE/DDW 2022, 2022. e-Pub 2022.
Nehme F, Lee JH. Impact of inconclusive endoscopic ultrasound-guided fine-needle aspiration on the management and outcomes of patients with solid pancreatic masses at a tertiary referral center. ASGE/DDW 2022, 2022. e-Pub 2022.
Nehme F, Ge P, Coronel E, Weston B, Ross W, Yu A, Liu C, Lum P, Ali F, Lee J. Endoscopic ultrasound evaluation of primary pancreatic lymphoma compared to adenocarcinoma: a case-control study. ASGE/DDW 2022, 2022. e-Pub 2022.
Nehme F, Lee JH. Combination testing of intracystic glucose and cea improves diagnostic accuracy of pancreatic cystic lesions. ASGE/DDW 2022, 2022. e-Pub 2022.
Nehme F, Lee JH. The combination of cyst fluid glucose and string sign increases the diagnostic accuracy of mucinous pancreatic cysts. ASGE/DDW 2022, 2022. e-Pub 2022.
Nehme F, Lee JH. Efficacy of anchoring fully covered esophageal metal stents to prevent migration: a case-control study. ASGE/DDW 2022, 2022. e-Pub 2022.
Nehme F, Lee JH. Factors associated with migration of fully-covered esophageal metal stents. ASGE/DDW 2022, 2022. e-Pub 2022.
Nehme F, Yu A, Ali F, Liu C, Coronel E, Weston B, Ross W, Ge P, Lum P, Low D, Lee JH. Differential diagnosis and management of subcentimeter solid pancreatic lesions. ASGE/DDW 2022, 2022. e-Pub 2022.
Ali F, Lee JH. Palliation of malignant hilar biliary obstruction with bilateral plastic or metal stent placement - a cost effectiveness analysis. ASGE/DDW 2022, 2022. e-Pub 2022.
Ali F, Lee JH. Bilateral plastic stent versus self expanding metal stent deployment for palliation of malignant hilar biliary obstruction - a meta-analytic evidence profile. ASGE/DDW 2022, 2022. e-Pub 2022.
Ali F, Lee JH. Endoscopic submucosal dissection of esophagastric junction lesions- a pooled analysis and comparative meta-analysis of Barrett's adenocarcinoma and gastric adenocarcinoma. ASGE/DDW 2022, 2022. e-Pub 2022.
Nehme F, Lee JH. The use of a flexible rigidizing overtube for endoscopic retrograde cholangiopancreatography in post pancreaticoduodenectomy. ASGE/DDW 2022, 2022. e-Pub 2022.
Nehme F, Lee JH. Diagnostic accuracy and utility of eus-fna for incidental subcentimeter pancreatic solid lesions. ASGE/DDW 2022, 2022. e-Pub 2022.
Coronel M, Lee JH. Outcomes of duodenal stent placement for malignant gastric outlet obstruction. Experience for a large tertiary care center. ACG 2021, 2021. e-Pub 2021.
Yu A, Kumar S, Coronel M, Coronel E, Ge PS, Bhutani MS, Weston BR, Ross WA, Lee, JH. Acute pancreatitis after endoscopic ultrasound guided sampling of pancreatic lesions. DDW 2021, 2021. e-Pub 2021.
Yu A, Emelogu IK, Coronel M, Coronel E, Ge PS, Weston BR, Bhutani MS, Ross WA, Kumar S, Lee JH. Long-term surveillance of pancreatic cysts can detect cancer early, but better predictors are needed. DDW 2021, 2021. e-Pub 2021.
Bahdi F, Yu A, Emelogu IK, Coronel M, Ge PS, Coronel E, Weston BR, Lynch PM, Ross WA, Kumar S, Lee JH. Esophageal stent placement for management of malignant dysphagia. DDW 2021, 2021. e-Pub 2021.
Emelogu IK, Bahdi F, Yu A, Coronel M, Coronel E, Ge PS, Weston BR, Ross, WA, Lynch PM, Kumar, S, Lee JH. Migration of esophageal stents placed for malignant obstruction. DDW 2021, 2021. e-Pub 2021.
Kumar S, Bahdi F, Yu A, Emelogu IK, Coronel M, Coronel E, Ge PS, Weston BR, Lynch PM, Lee JH. Trends in the performance and use of esophageal stents for malignant dysphagia over time. DDW 2021, 2021. e-Pub 2021.
Emelogu IK, Kumar S, Yu A, Coronel M, Coronel E, Ge PS, Weston BR, Ross WA, Lee JH. Metal biliary stents for biliary obstruction in cholangiocarcinoma. DDW 2021, 2021. e-Pub 2021.
Kumar S, Coronel E, Coronel M, Ge PS, Bhutani MS, Weston BR, Ross WA, Lee JH. Endoscopic submucosal dissection of lesions with an underlying or adjacent varix – a systematic review of the literature. DDW 2021, 2021. e-Pub 2021.
Lee JH. Endoscopic submucosal dissection in patients with liver cirrhosis – a meta-analytic efficacy and adverse effect profile. DDW 2021, 2021. e-Pub 2021.
Kumar S, Coronel E, Coronel M, Ge PS, Bhutani MS, Weston BR, Ross WA, Leeb JH. Endoscopic ultrasound characteristics of pancreatic neuroendocrine tumors. DDW 2021, 2021. e-Pub 2021.
Coronel M, Bahdi F, Kumar D, Kumar S, Lum P, Nogueras G, Weston B, Ross WA, Raju GS, Ge PS, Coronel E, Lee JH. The use of EUS and ERCP in the diagnosis of extrahepatic biliary cholangiocarcinoma. Experience from a large tertiary care center. DDW 2021, 2021. e-Pub 2021.
Coronel M, Ge PS, Kumar S, Lum P, Weston B, Ross WA, Raju GS, Lee JH, Coronel E. Efficacy and safety of endoscopic fixation to prevent migration of esophageal stents. A tertiary care center experience. DDW 2021, 2021. e-Pub 2021.
Coronel M, Yu A, Kumar S, Ge PS, Nogueras G, Lum P, Weston B, Ross WA, Raju GS, Coronel E, Lee JH. Clinical outcomes of gastric and duodenal neuroendocrine tumors. Experience from a large tertiary care cancer center. DDW 2021, 2021. e-Pub 2021.
Coronel M, Kumar D, Bahdi F, Kumar S, Lum P, Nogueras G, Weston B, Ross WA, Raju GS, Ge PS, Coronel E, Lee JH. The use of ERCP in the diagnosis of indeterminate biliary strictures. Experience from a large tertiary care center. DDW 2021, 2021. e-Pub 2021.
Low DJ, Nakshabandi A, Coronel E, Ge PS, Weston BR, Ross WA, Lee J. Percutaneous transhepatic biliary drainage after failed endoscopic retrograde pancreatography in unresectable perihilar cholangiocarcinoma. DDW 2023 8(2):E203–E210, 2020. e-Pub 2020. PMID: 32010755.
Lee JH. Evaluating the impact of advanced endoscopy fellow involvement on endoscopic ultrasound (EUS) with fine needle aspiration (FNA) and endoscopic retrograde cholangiopancreatography (ERCP). DDW 2020, 2020. e-Pub 2020.
Lee JH. Evaluating the impact of attending physician career phase on endoscopic ultrasound (EUS) with fine needle aspiration (FNA) safety and efficiency. DDW 2020, 2020. e-Pub 2020.
Lee JH. Evaluating endoscopic ultrasound (EUS) with fine needle aspiration (FNA) for the diagnosis of pancreatic neuroendocrine tumors; a ten-year, retrospective analysis. DDW 2020, 2020. e-Pub 2020.
Lee JH. Evaluating the safety and efficacy of endoscopic ultrasound (EUS) with fine needle aspiration (FNA) for the diagnosis of cystic pancreatic lesions. DDW 2020, 2020. e-Pub 2020.
Lee JH. Efficacy, safety; and procedure characteristics of endoscopic ultrasound (EUS) with fine needle aspiration (FNA) for the diagnosis of suspected pancreatic adenocarcinoma. DDW 2020, 2020. e-Pub 2020.
Lee JH. Endoscopic ultrasound (EUS) with fine needle aspiration (FNA) for the evaluation of pancreatic metastases and lymphoma. DDW 2020, 2020. e-Pub 2020.
Lee JH. Endoscopic insertion of enteral self-expanding metal stents for gastric outlet or afferent limb obstruction in patients with a surgically altered anatomy; a meta-analysis. DDW 2020, 2020. e-Pub 2020.
Lee JH. Endoscopic ultrasound-guided gastroenterostomy for the treatment of gastric outlet obstruction; a meta-analysis of direct and balloon-assisted approach. DDW 2020, 2020. e-Pub 2020.
Lee JH. Clinical Utility of Endoscopic Ultrasound-Guided Deployment Of Lumen-Apposing Metal Stents For Malignant Afferent Limb Syndrome; A Descriptive Analysis. DDW 2020, 2020. e-Pub 2020.
Lee JH. Endoscopic radio frequency ablation in the management of unresectable hilar and distal cholangiocarcinoma: A Systemic review and meta-analysis. DDW 2019, 2019. e-Pub 2019.
Lee JH. Efficacy of Lumen-apposing metal stent insertion in patients with malignant pancreatic fluid collections: A tertiary Cancer Center Experience. DDW 2019, 2019. e-Pub 2019.
Lee JH. Characteristics of Gastrointestinal Stromal tumors using endoscopic ultrasound. DDW 2019, 2019. e-Pub 2019.
Lee JH. Characteristics and Endoscopic Management of Gastric neuroendocrine tumors. DDW 2019, 2019. e-Pub 2019.
Lee JH. Role of Argon Plasma coagulation in the setting of endoscopic retrograde cholangiopancreatography. DDW 2019, 2019. e-Pub 2019.
Lee JH. Endoscopic Management of Duodenal Nueroendocrine tumors. DDW 2019, 2019. e-Pub 2019.
Lee JH. Outcomes of Endoscoopic Resection of non-ampullary duodenal adenomas: A tertiary Cancer Center Experience. DDW 2019, 2019. e-Pub 2019.
Lee JH. Utility of Endoscopic Ultrasound in the Diagnosis of Cholangiocarcinoma. DDW 2019, 2019. e-Pub 2019.
Lee JH. Esophageal Stent Placement for Post-operative Complications in Patients with Esophageal surgery secondary to malignancy. DDW 2019, 2019. e-Pub 2019.
Lee JH. Peroral Single-operator cholangioscopy for diagnosis and management of Malignant Strictures: A Tertiary Cancer Care Center Experience. DDW 2019, 2019. e-Pub 2019.
Lee JH. EUS-guided biliary drainage after failed ERCP: A tertiary Cancer Center Experience. DDW 2019, 2019. e-Pub 2019.
Lee JH. Management of Ampullary Lesions: 16 Years of experience from a tertiary cancer center. DDW 2019, 2019. e-Pub 2019.
Lee JH. The single session: feasibility and outcomes of combined EUS-FNA and ERCP procedures. A 5-year tertiary care center experience. DDW 2018, 2018. e-Pub 2018.
Lee JH. Endoscopic management and outcomes of ampullary lesions. A 5-year tertiary care center experience. DDW 2018, 2018. e-Pub 2018.
Lee JH. Endoscopic ultrasound guided needle aspiration with immediate on-site cytology evaluation and outcomes for pancreatic adenocarcinoma. A 5-year tertiary care center experience. DDW 2018, 2018. e-Pub 2018.
Lee JH. Non-invasive imaging modalities as an adjunct to EUS-FNA with on-site cytology evaluation for neoplastic solid pancreatic lesions. A tertiary care center experience. DDW 2018, 2018. e-Pub 2018.
Lee JH. Clinical utility of the 2017 Fukuoka consensus and 2015 American Gastroenterological Association guidelines in the management of intraductal papillary mucinous neoplasms (IPMNS). DDW 2018, 2018. e-Pub 2018.
Lee JH. Long-term outcomes in patients who underwent surgery after EUS-FNA diagnosis of neoplastic solid pancreatic lesions (NSPL). A 5-year tertiary care center experience. DDW 2018, 2018. e-Pub 2018.
Lee JH. Characterization and predictors of disease progression in pancreatic neuroendocrine tumors diagnosed by EUS-FNA. A 10-year tertiary care center experience. DDW 2018, 2018. e-Pub 2018.
Lee JH. Diagnostic value of EUS-FNA for metastatic lesions to the pancreas. A 10-year tertiary care center experience. DDW 2018, 2018. e-Pub 2018.
Lee JH. The characteristics, pathologic predictors of recurrence, and utility of surgical resection of solid pseudopapillary neoplasms: a 20 year experience at a tertiary cancer center. DDW 2018, 2018. e-Pub 2018.
Lee JH, Emelogu IK, Coronel E, Nogueras-Gonzalez GM, Lum P, Ross WA, Raju GS, Lynch PM, Thirumurthi S, Stroehlein JR, Wang Y, You YN, Weston BR. Are SEMS (self-expanding metal stents) a safe and successful bridge to surgery or definitive therapy for malignant colorectal obstruction (MCO), particularly in patients treated with bevacizumab, a VEGF inhibitor? A tertiary cancer center experience. DDW 2018, 2018. e-Pub 2018.
Lee JH. Comparison of the performance of covered metal stents and uncovered metal stents in the management of malignant biliary strictures (MBO) in 1012 patients. DDW 2018, 2018. e-Pub 2018.
Gulhati P, Prakash L, Katz MH, Wang X, Javle MM, Shroff RT, Fogelman DR, Lee JE, Tzeng CD, H Lee JH, Weston B, Tamm EP, Bhosale P, Koay EJ, Maitra A, Wang H, Wolff RA, Varadhachary GR. First line gemcitabine and nab-paclitaxel chemotherapy for localized pancreatic ductal adenocarcinoma. ASCO 2018, 2018. e-Pub 2018.
Harada K, Wu CC, Wang X, Kaya DM, Amlashi FG, Lin Q, Blum MA, Maru DM, Weston B, Lee JH, Bhutani MS, Hofstetter WL, Nguyen Q, Ajani JA. Metabolic activity to predict clinical response and prognosis in esophageal adenocarcinoma patients treated with bimodality. ASCO 2018, 2018. e-Pub 2018.
Kaya DM, Nogueras-Gonzalez GM, Estrella J, Harada K, Amlashi FG, Lin Q, Blum Murphy MA, Lee JH, an Weston BR, Bhutani MS, Matamoros Jr A, Sagebiel TL, Devine CE, Patnana M, Minsky BD, Das P, Badgwell BD, Ajani JA. Potentially curable gastric adenocarcinoma (GAC) patients treated without surgery. ASCO 2018, 2018. e-Pub 2018.
Coronel E, Kukreja K, Glover M, Ali F, Nogueras-Gonzalez G, Lum P, Ross W, Weston B, Bhutani M, Lee JE, Katz M, Lee JH. Endoscopic ultrasound guided needle aspiration with immediate on-site cytology evaluation and outcomes for pancreatic adenocarcinoma. A 5-year tertiary care center experience. DDW 2018, 2018. e-Pub 2018.
Coronel E, Glover M, Kukreja K, Ali F, Gonzalez GN, Lanke G, Lum P, Ross W, Weston B, Lee JE, Bhutani M, Lee JH. Characterization and predictors of disease progression in pancreatic neuroendocrine tumors diagnosed by EUS-FNA. A 10-year tertiary care center experience. DDW 2018, 2018. e-Pub 2018.
Coronel E, Kukreja K, Glover M, Ali F, Nogueras-Gonzalez G, Lum P, Ross W, Weston B, Bhutani M, Lee JH. Diagnostic value of EUS-FNA for metastatic lesions to the pancreas. A 10-year tertiary care center experience. DDW 2018, 2018. e-Pub 2018.
Kukreja K, Coronel E, Glover M, Ali F, Nogueras-Gonzalez G, Lum P, Ross W, Weston B, Bhutani M, Lee JH. The diagnostic value of EUS-FNA and outcomes in patients with rare pancreatic malignancies. A 10-year tertiary care center experience. DDW 2018, 2018. e-Pub 2018.
Glover M, Coronel E, Kukreja K, Ali F, Nogueras-Gonzalez G, Lum P, Ross W, Weston B, Bhutani M, Lee JH. Non-invasive imaging modalities as an adjunct to eus-fna with on-site cytology evaluation for neoplastic solid pancreatic lesions. A tertiary care center experience. DDW 2018, 2018. e-Pub 2018.
Coronel E, Glover M, Kukreja K, Nogueras-Gonzalez G, Lum P, Arnold B, Ali F, Ross W, Raju GS, Weston B, Bhutani M, Lanke G, Katz M, Lee JE, Lee JH. The single session: feasibility and outcomes of combined EUS-FNA and ERCP procedures. A 5-year tertiary care center experience. DDW 2018, 2018. e-Pub 2018.
Coronel E, Glover M, Kukreja K, Nogueras-Gonzalez G, Lum P, Ali F, Ross W, Weston B, Bhutani M, Lee JE, Katz M, Lee JH. Long-term outcomes in patients who underwent surgery after eus-fna diagnosis of neoplastic solid pancreatic lesions (nspl). A 5-year tertiary care center experience. DDW 2018, 2018. e-Pub 2018.
Coronel E, Patel J, Ross W, Nogueras-Gonzalez G, Weston B, Katz M, Lee JE, Lynch P, Lee JH. Endoscopic management and outcomes of ampullary lesions. A 5-year tertiary care center experience. DDW 2018, 2018. e-Pub 2018.
Coronel E, Lanke G, Nogueras-Gonzalez G, Ross W, Weston B, Bhutani M, Katz M, Kim M, Lee JH. Clinical utility of the 2017 Fukuoka consensus and 2015 American Gastroenterological Association guidelines in the management of intraductal papillary mucinous neoplasms (ipmns). DDW 2018, 2018. e-Pub 2018.
Coronel E, Lee J, Ross W, Davila M, Bhutani M, Raju GS, Lynch P, Weston B. Efficacy of self expandable metal stents in extrinsic malignant colonic obstruction. A 10-year tertiary care center experience. DDW 2018, 2018. e-Pub 2018.
Coronel E, Abu-sbeih H, Gonzales Nogueras G, Sutaria A, Kim M, Weston B, Lum P, Ross W, Katz M, Lee JE, Lee JH, Bhutani MS. Long-term outcomes of mucinous pancreatic cystic lesions in cancer survivors or patients with extra-pancreatic malignancy. DDW 2018, 2018. e-Pub 2018.
Abu-Sbeih H, Coronel E, Lum P, Shuttlesworth G, Lee J, Wang Y. The yield of endoscopic evaluation in the management of gastrointestinal bleeding in cancer patients with thrombocytopenia. DDW 2018, 2018. e-Pub 2018.
Abu-Sbeih H, Coronel E, Chen HC, Wang X, Bhutani M, Lee JH, Raju GS, Ross W, Stroehlein J, Lum P, Shuttlesworth G, Wang Y. Safety of endoscopic procedures in cancer patients with neutropenia: five years cancer center experience. DDW 2018, 2018. e-Pub 2018.
Abu-Sbeih H, Coronel E, Chen HC, Wang X, Bhutani M, Lee J, Raju GS, Ross W, Stroehlein J, Lum P, Shuttlesworth G, Wang Y. Safety of endoscopic procedures in cancer patients with thrombocytopenia: a tertiary care cancer center experience. DDW 2018, 2018. e-Pub 2018.
Lee JH. Taxane-based or Platinum-based combination chemotherapy given concurrently with radiation followed by surgery resulting in high cure rates in esophageal cancer patients. ASCO 2018, 2018. e-Pub 2018.
Petersen B, Arain M, Baron T, Lee J, Branch S, Draganov P, Al-Kaade S, Mullady D, Bennette R, Hemerick J, Ross D, Dassner S, Foss A, Pearlman A, Saunders J, Rivera-Bermudez M, Scutti J, Clerc C, Swanson L, Amos D, Favreau J. Assessment of the effects of paclitaxel eluting SEMS on naive porcine biliary tissue. Prometheus UEGW, 2018. e-Pub 2018.
DaVee T, Deep A, Khuwaja S, Khurana A, Nogueras-Gonzalez GM, Lum PJ, Weston BR, Lee JH. Malignant intrahepatic biliary obstructions: do antibiotics prevent cholangitis in patients with incomplete biliary drainage?. DDW 2017, 2017. e-Pub 2017.
DaVee T, Lanke G, Kukreja K, Nogueras-Gonzalez GM, Lum PJ, Bhutani MS, Ross WA, Ajani JA, Lee JH. Echosonographic characteristics of regional lymph nodes are predictive of malignant spread in esophageal cancer. DDW 2017, 2017. e-Pub 2017.
DaVee T, Qazilbash M, Lanke G, Arora A, Nogueras-Gonzalez GM, Lum PJ, Shafi MA, Weston B, Ajani JA, Lee JH. Esophageal cancer regional lymph node staging: Endoscopic ultrasound versus positron emission tomography; which is better?. DDW 2017, 2017. e-Pub 2017.
DaVee T, Qazilbash M, Nogueras-Gonzalez GM, Lum PJ, Lanke G, Kukreja K, Shafi MA, Bhutani MS, Lee JH. Is endoscopic ultrasound more accurate than computed tomography in esophageal cancer staging?. DDW 2017, 2017. e-Pub 2017.
DaVee T, Lanke G, Kukreja K, Nogueras-Gonzalez GM, Lum PJ, Bhutani MS, Ross WA, Lee JH. Does histologic grade of esophageal cancer impact the accuracy of diagnostic staging modalities. DDW 2017, 2017. e-Pub 2017.
DaVee T, Kukreja K, Glover M, Lanke G, Nogueras-Gonzalez GM, Lum PJ, Ross WA, Lee JH. Delayed pancreatitis risk with chemoradiation after metal biliary stent placement for malignant biliary obstruction. DDW 2017, 2017. e-Pub 2017.
DaVee T, Kukreja K, Glover M, Lanke G, Nogueras-Gonzalez GM, Raju GS, Ross WA, Weston BR, Lee JH. Post ERCP cholecystitis after metal biliary stent placement: Do proximal malignant biliary strictures increase the risk?. DDW 2017, 2017. e-Pub 2017.
DaVee T, Kukreja K, Glover M, Lanke G, Nogueras-Gonzalez GM, Lum PJ, Ross WA, Lee JH. Does chemoradiation increase ascending cholangitis risk after metal biliary stent placement for malignant biliary obstruction?. DDW 2017, 2017. e-Pub 2017.
DaVee T, Glover M, Kukreja K, Nogueras-Gonzalez GM, Weston BR, Ross WA, Raju GS, Lee JH. Does chemoradiation prevent recurrent biliary obstruction following metal biliary stent placement?. DDW 2017, 2017. e-Pub 2017.
DaVee T, Lanke G, Kukreja K, Arora A, Nogueras-Gonzalez GM, Lum PJ, Bhutani MS, Weston B, Lee JH. Does the accuracy of regional lymph node staging vary between esophageal squamous cell carcinoma and esophageal adenocarcinoma?. DDW 2017, 2017. e-Pub 2017.
DaVee T, Kukreja K, Glover M, Nogueras-Gonzalez GM, Raju GS, Ross WA, Weston BR, Lee JH. Does sphincterotomy reduce post-ERCP pancreatitis risk after covered metal biliary stent placement for malignant biliary obstruction?. DDW 2017, 2017. e-Pub 2017.
DaVee T, Khuwaja S, Deep A, Lanke G, Nogueras-Gonzalez GM, Ross WA, Lee JH. Are prophylactic necessary to reduce the risk of post ERCP related infections in cancer patients?. DDW 2017, 2017. e-Pub 2017.
DaVee T, Deep A, Khuwaja S, Lanke G, Nogueras-Gonzalez GM, Raju GS, Lee JH. A pragmatic evaluation of targets set by the American Society for Gastrointestinal Endoscopy for ERCP priority quality indicators in a cancer population. DDW 2017, 2017. e-Pub 2017.
DaVee T, Deep A, Khuwaja S, Thirumurthi S, Nogueras-Gonzalez GM, Lanke G, Lum PJ, Ross WA, Weston BR, Lee JH. Does poor abdominal wall transillumniation predict failed placement of percutaneous endoscopic gastrostomy tubes?. DDW 2017, 2017. e-Pub 2017.
DaVee T, Deep A, Khuwaja S, Thirumurthi S, Nogueras-Gonzalez GM, Lum PJ, Raju GS, Lynch PM, Lee JH. Obesity does not affect adverse event risk following percutaneous endoscopic gastrostomy tube placement. DDW 2017, 2017. e-Pub 2017.
DaVee T, Deep A, Khuwaja S, Thirumurthi S, Nogueras-Gonzalez GM, Lum PJ, Bhutani MS, Miller E, Lee JH. Does prior abdominal surgery increase the incidence of adverse events following percutaneous endoscopic gastrostomy tube placement. DDW 2017, 2017. e-Pub 2017.
DaVee T, Deep A, Khuwaja S, Nogueras-Gonzalez GM, Thirumurthi S, Hurana A, Lum PJ, Shafi MZ, Blechacz B, Lee JH. The effect of prophylactic antibiotic timing on peristomal cellulitis following percutaneous endoscopic gastrostomy tube placement. DDW 2017, 2017. e-Pub 2017.
Kaya DM, Wang X, Harada K, Blum-Murphy MA, Das P, Minsky B, Estrella JS, Lin Q, Amlashi FG, Lee JH, Weston B, Bhutani MS, Matamoros Jr A, Sagebiel T, Wu CC, Hofstetter W, Badgwell BD, Ajani AJ. Long-term survival in 101 metastatic gastroesophageal cancer (mGEAC) patients eventually treated consolidative local therapy. ASCO 2016, 2016. e-Pub 2016.
Papafragkakis C, Thaiudom S, Lanke G, Chakinala RC, Qiao W, William R, Weston BR, Davila ML, Raju GS, Lee JH. Outcomes of Stent-in-Stent (SIS) in the Management of Malignant Distal Biliary Obstruction (MDBO). DDW 2016, 2016. e-Pub 2016.
Papafragkakis C, Thaiudom S, Lanke G, Chakinala RC, Wang X, Bhutani MS, Lee JH. Pancreatic Cancer Screening (PSC in High Risk Individuals (HRI) with Genetic Mutations. DDW 2016, 2016. e-Pub 2016.
Papafragkakis C, Thaiudom S, Gandhi L, Chakinala RC, Qiao W, Jaganmohan S, Lee JH. Clear Bile (CB) and Dark Bile (DB) in Malignant Biliary Obstruction with Naive Papilla: Does It Affect Survival?. DDW 2016, 2016. e-Pub 2016.
Raju GS, Lum P, Ross W, Lynch PM, Miller E, Thirumurthi S, Blechacz B, Lee JH, Shafi MA, Bhutani MS, Asif R, Weston BR, Davla ML, Stroehlein JR. Outcome of a protocol driven endoscopic resection of patients with large colon polyps (>20mm) results in low complications and recurrence. ASGE 2016, 2016. e-Pub 2016.
Raju GS, Lum P, Ross W, Lynch PM, Thirumurthi S, Miller E, Blechacz B, Weston BR, Shafi M, Bhutani MS, Lee J, Davila ML, Stroehlein JR. Better management of patients with large colon polyps requires improvement in the knowledge gaps among referring endoscopists. ASGE 2016, 2016. e-Pub 2016.
Lee JH, Chan C, Lynch PM, Ross WA, Thirumurthi S, Bhutani MS, Weston B, Raju GS, Cassani LS. Safety and Effectiveness of Cap-assisted Endoscopic Mucosal Resection (EMR-C) and Conventional Endoscopic Mucosal Resection (EMR) for Large Nonampullary Duodenal Polyps (NADA) in Patients with Familial Adenomatous Polyposis (FAP) or Sporadic Duodenal Adenoma (SDA). ACG 2015, 2015. e-Pub 2015.
Kirtane T, Cassani L, Davis DW, Lee JH. Endoscopy Video Forum: Endoscopic Ultrasound Features of Pancreatic Cystic Neoplasms. ACG 2015, 2015. e-Pub 2015.
Lee TJ, Raju GS, Lee JH. Cap-assisted Endoscopic Mucosal Resection of A Large Non-ampullary Duodenal Adenoma. ACG 2015, 2015. e-Pub 2015.
Slack RS, Ross WA, Lum P, Thirumurthi S, Weston B, Miller E, Lee JH, Shafi M, Davila M, Bresalier RS, Lynch PM, Shuttlesworth G, Mishra L, Stroehlein JR, Raju G. Reporting Adenoma Detection Rate Confidence Intervals Provide Better Feedback about Endoscopists' Performance. DDW 2015, 2015. e-Pub 2015.
Shin EJ, Goggins MG, Chulick RD, Petersen GM, Hruban RH, Cosby H, Topazian M, Syngal S, Farrell JJ, Lee J, Khashab M, Lennon AM, Yeo CJ, Canto MI. Quality of Life and Cancer Worry of Individuals with Increased Risk for Familial Pancreatic Cancer. UEG Week 2015, 2015. e-Pub 2015.
Gavini H, Chan C, Salvador D, Singh C, Ross W, Bhutani M, Weston BR, Lee JH. Evaluating the role of EUS-FNA in the diagnosis of metastasis to the pancreas: Results from a tertiary cancer center. ACG 2014, 2014. e-Pub 2014.
Gavini H, Chouhan JS, Xiao L, Ross W, Weston BR, Raj G, Davila M, Javle M, Lee JH. The efficacy of ERCP and PTBD and comparison of survival in unilateral versus bilateral drainage in patients cholangiocarcinoma: Experience from a single tertiary cancer specialty institute. ACG 2014, 2014. e-Pub 2014.
Gavini H, Ahmad M, Singh C, Ross W, Bhutani M, Weston BR, Lee JH. Imaging characteristics, role of EUS-FNA and prognosis in patients with pancreatic lymphoma. ACG 2014, 2014. e-Pub 2014.
Gavini H, Chouhan JS, Xiao L, Kwak N, Ross W, Bhutani M, Weston BR, Lee JH. The diagnostic yield of imaging modalities in screening for pancreatic cancer in symptomatic high risk individuals: Experience from a tertiary cancer center. ACG 2014, 2014. e-Pub 2014.
Gavini, Hemanth, Salvador DL, Chan C, Singh C, Ross W, Bhutani M, Weston BR, Lee JH. Comparison of imaging characteristics of CT, MRI, PET and EUS in the evaluation of metastasis to the pancreas: Results from a single tertiary cancer center. ACG, 2014. e-Pub 2014.
Kutlu O, Rueth NM, Vauthey JN, Katz MH, Lee JH, Fleming JB, Aloia TT, Lee JE, You YN, Lynch PM, Conrad C. Minimally Invasive Duodenoampullectomy in patients with familial adenomatous polyposis. DDW 2014, 2014. e-Pub 2014.
Gavini H, Sheu-Woc W, Arukala V, Lynch PM, Mishra L, Fleming JB, Thirumurthi S, Ross WA, Conrad C, Weston BR, Lee JH. Difference in characteristics and tumor biology of ampullary adenomas in patients with FAP and sporadic adenomas. DDW 2014, 2014. e-Pub 2014.
Gavini H, Sheu-Woc W, Singh A, Ross WA, Ajani JA, Bhutani MS, Weston BR, Hofstetter WL, Davila ML, Raju Gottumukkala S, Welsh JW, Lee JH. Is a repeat endoscopy (EGD) necessary when referred for staging of newly diagnosed esophageal cancer?. DDW 2014, 2014. e-Pub 2014.
Gavini H, Sheu-Woc W, Lee JH. Outcomes of Unilateral vs Bilateral drainage in Cholangiocarcinoma-Report from a Cancer Specialty Institute (CSI). DDW 2014, 2014. e-Pub 2014.
Krishna SG, Bhattacharya, A, Ladha HS, Porter K, Ross WA, Bhutani MS, Weston BR, Katz MH, Fleming JB, Lee JH. Diagnosis of pancreatic adenocarcinoma: A review of 723 patients with solid pancreatic neoplasms at a single center. DDW 2014, 2014. e-Pub 2014.
Raju GS, Ross WA, Lum P, Lynch PM, Slack R, Miller E, Weston B, Davila ML, Thirumurthi S, Bhutani MS, Shafi M, Bresalier RS, Dekovich AA, Lee JH, Guha S, Blechacz B, Rashid A, Routbort M, Shuttlesworth G, Mishra L, Stroehlein JR. Natural Language Processing (NLP) as an alternative to manual reporting of colonoscopy quality metrics. DDW 2014, 2014. e-Pub 2014.
Atiq M, Lee JH, Ross WA, Bhutani MS. Is it safe to follow cystic pancreatic neoplasms if immediate surgery is not undertaken?. DDW 2014, 2014. e-Pub 2014.
Shiozaki H, Sudo K, Wadhwa R, Hofstetter WL, Skinner HD, Komaki R, Lee JH, Weston B, Bhutani MS, Maru DM, Blum MA, Ajani JA. Distribution and timing of distant metastasis (DM) after definitive therapy for patients with esophageal and esophagogastric junction (E-EGJ) cancer. ASCO 2014, 2014. e-Pub 2014.
Sudo K, Wang X, Wadhwa R, Shiozaki, Hofstetter WL, Rice DC, Lee JH, Bhutani MS, Weston B, Skinner HD, Komaki R, Maru DM, Blum MA, Ajani JA. Clinical parameters' model for predicting distant metastasis (DM) following definitive therapy in patients with localized esophageal and esophagogastric junction (E-EGJ) cancer. ASCO 2014, 2014. e-Pub 2014.
Wadhwa R, Wang X, Izzo J, Skinner HD, Lee JH, Bhutani MS, Weston B, Ross WA, Hofstetter WL, Maru DM, Rice DC, Sudo K, Shiozaki H, Blum MA, Chen Q, Jin J, Song S, Baladandayuthapani B, Ajani JA. Pre-treatment nuclear Gli-1 labeling indices (lIs) correlate with initial SUV (iSUV) in esophageal cancer (EC) patients undergoing trimodality therapy (TMT). A potential pathway to esophageal preservation. ASCO 2014, 2014. e-Pub 2014.
Singh A, Kwak NH, Ladha HS, Bhattacharya A, Krishna SG, Ross WA, Bhutani MS, Tamm EP, Bhosale P, Raju GS, Fleming JB, Lee JH. Yield of Endoscopic Ultrasound in Screening for Pancreatic Cancer at a Tertiary Cancer Center. Digestive Disease Week 2013, 2013. e-Pub 2013.
Singh A, Bhattacharya A, Ladha HS, Kwak N, Krishna SG, Ross WA, Bhutani MS, Ajani JA, Erasmus J, Hofstetter WL, Swisher S, Lee JH. Comparison of Lymph Node Detection on PET and EUS in Patients with Esophageal Cancer. Digestive Disease Week 2013, 2013. e-Pub 2013.
Singh A, Bhattacharya A, Ladha HS, Krishna SG, Ross WA, Bhutani MS, Ajani JA, Hofstetter WL, Lee JH. Is Second Look for Staging of Newly Diagnosed Esophageal Cancer Necessary?. DDW 2013, 2013. e-Pub 2013.
Singh A, Hofstetter WL, Bhattacharya A, Ladha HS, Qiao W, Ross WA, Bhutani MS, Krishna SG, Ajani JA, Maru D, Lee JH. Accuracy of Endoscopic Ultrasound in Differentiation of Mucosal and Submucosal Esophageal Cancer at a Tertiary Cancer Care Center. Digestive Disease Week 2013, 2013. e-Pub 2013.
Singh A, Bhattacharya A, Xiao L, Ross WA, Dekovich AA, Lee JE, Lynch PM, Davila ML, Krishna SG, Lee JH. Comparison of Gastrojejunostomy and Enteral SEMS in Management of Malignant Gastric Outlet Obstruction-A Single Tertiary Care Cancer Center Experience. Digestive Disease Week 2013, 2013. e-Pub 2013.
Singh, Ladha HS, Bhattacharya A, Welsh JW, Qiao W, Krishna SG, Ross WA, Bhutani MS, Ajani JA, Hofstetter WL, Swisher S, Lee JH. Is Dilation Necessary to Complete EUS staging for esophageal cancer?. Digestive Disease Week 2013, 2013. e-Pub 2013.
Singh A, Ross WA, Krishna SG, Bhattacharya A, Ladha HS, Noueras Gonzalez GM, Varadhachary GR, Fleming JB, Raju GS, Lee JH. Management of Self-Expanding Metal Stent Occlusion in Patients with Malignant Biliary Obstruction. Digestive Disease Week 2013, 2013. e-Pub 2013.
Krishna SG, Bhattacharya A, Ladha HS, Singh A, Ross WA, Bhutani MS, Fleming JB, Lee JG. Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for diagnosis of cystic pancreatic lesions (CPL): Comprehensive evaluation, multidisciplinary dialogue and continued challenges at a tertiary oncology center. Digestive Disease Week 2013, 2013. e-Pub 2013.
Krishna SG, Bhattacharya A, Ladha HS, Singh A, Ross WA, Bhutani MS, Fleming JB, Lee JH. Pretest evaluation of solid pancreatic lesions (SPLs) and utility of EUS-guided fine needle aspiration (EUS-FNA) for diagnostic differentiation between malignant tumors. Digestive Disease Week 2013, 2013. e-Pub 2013.
Krishna SG, Bhattacharya A, Ladha HS, Singh A, Ross WA, Bhutani MS, Fleming JB, Lee JH. Pretest probability and diagnostic accuracy of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for pancreatic adenocarcinoma at a tertiary care oncology center: A 12 year experience. Digestive Disease Week 2013, 2013. e-Pub 2013.
Taketa T, Xiao L, Suzuki A, Blum MA, Sudo K, Lee JH, Weston B, Bhutani MS, Lin SH, Wadhwa R, Swisher S, Hofstetter WL, Ajani JA. 16-covariate propensity score matching between trimodality (TMT)-eligible esophagogastric cancer (EC) patients who had surgery and those who declined surgery after preoperative chemoradiation. ASCO 2013-Gastrointestinal Cancers Symposium, 2013. e-Pub 2013.
Lee JH. Trimodality therapy (TMT) for patients with esophageal and esophagogastric junction (E-EGJ) cancer is associated with low rate of local-regional relapse and rare luminal-only relapse: implications for the surveillance strategy. ASCO 2013-Gastrointestinal Cancers Symposium, 2013. e-Pub 2013.
Wadhwa R, Taketa T, Correa AM, Sudo K, Blum MA, Campagna MC, Komaki R, Lee JH, Bhutani M, Weston B, Liao Z, Rice DC, Swisher SG, Hofstetter WL, Ajani JA. Incidence of brain metastases following trimodality therapy (TMT) in patients with esophageal and gastroesophageal (E-EGCJ) cancer. ASCO 2013 Gastrointestinal Cancers Symposium, 2013. e-Pub 2013.
Campagna MC, Taketa T, Correa AM, Suo K, Blum MA, Wadhwa R, Komak R, Lee JH, Bhutani MS, Weston B, Liao ZX, Rice DC, Swisher S, Hofstetter WL, Ajani JA. Association of Relapse in patients with esophageal and esophagogastric junction (E-GEJ) cancer is highly associated with surgical stage after trimodality therapy (TMT): Implications for customized surveillance. ASCO 2013 Gastrointestinal Cancers Symposium, 2013. e-Pub 2013.
Suzuki A, Xiao L, Taketa T, Sudo K, Blum MA, Komaki R, Liao ZX, Lee JH, Bhutani MS, Weston B, Hofstetter WL, Swisher S, Ajani JA. Various clinical outcomes n patients with esophageal or gastroesophageal junction (E-GEJ) adenocarcinoma undergoing trimodality therapy: Prognostic implications. ASCO 2013 Gastrointestinal Cancers Symposium, 2013. e-Pub 2013.
Shin EJ, Goggins MG, Schulick RD, Petersen GM, Hruban RH, Cosby H, Topazian M, Syngal S, Farrell JJ, Lee JH, Khashab M, Lennon AM, Yeo CJ, Canto MI. Quality of life and cancer worry of individuals with increased risk for familial pancreatic cancer. CAPS conference, 2013. e-Pub 2013.
Sudo K, Taketa T, Correa AM, Campagna MC, Wadhwa R, Blum MA, Komaki R, Lee JH, Bhutani MS, Weston B, Liao ZX, Rice DC, Swisher S, Hofstetter WL, Ajani JA. Association of trimodality therapy (TMT) with rate of local-regional relapse and rare luminal-only relapse for patients with esophageal and esophagogastric junction (E-EGJ) cancer: Implications for the surveillance strategy. ASCO 2013 Gastrointestinal Cancer Symposium, 2013. e-Pub 2013.
Hayashi Y, Xiao L, Suzuki A, Blum MA, Sabloff B, Taketa T, Maru DM, Welsh J, Lin SH, Weston B, Lee JH, Bhutani MS, Hofstetter WL, Swisher SG, Ajani JA. A nomogram associated with high probability of malignant nodes in the surgical specimen after trimodality therapy of patients with esophageal cancer (EC). ASCO 2012 Annual Meeting, 2012. e-Pub 2012.
Vadyala V, Krishna SG, Walker L, Mahometano L, Davila ML, Lee JH, Ross WA, Bhutani MS, Guha S, Stroehlein JR, Lynch PM, Raju GS. Clip closure after endoscopic mucosal resection (EMR) of > 20 mm lateral spreading tumors of the colon allows discharge of patients immediately after the procedure. ASGE DDW 2012, 2012. e-Pub 2012.
Krishna SG, Ross WA, Fleming JB, Bhutani MS, Foo WC, Raju GS, Weston BR, Dang SM, Lee JH. Large duodenal adenomas (> 1cm): is EUS necessary before endoscopic mucosal resection (EMR)?. DDW 2012, 2012. e-Pub 2012.
Krishna SG, Dang S, Ross WA, Foo WC, Lee JH. Pancreatic involvement in multiple myeloma: clinical and diagnostic features for the gastroenterologist. DDW 2012, 2012. e-Pub 2012.
Krishna SG, Fleming JB, Ross WA, Bhutani MS, Foo WC, Gong Y, Raju GS, Lee JH. Non-ampullary duodenal carcinoids: Role of endosonography and outcome of endoscopic mucosal resection. DDW 2012, 2012. e-Pub 2012.
Shin E, Topazian M, Syngal S, Farrell J, Goggins M, Saltzman JR, Lee JH. Radial Versus Linear and Second Look Endoscopic Ultrasound (EUS) Improved Detection of Pancreatic Lesions: A Randomized Tandem Study. DDW 2012, 2012. e-Pub 2012.
Wang W, Shpaner A, Krishna S, Ross WA, Bhutani MS, Tamm EP, Raju GS, Xiao L, Lee JH. Utilization of EUS-FNA in diagnosing pancreatic neoplasms without definitive masses on CT scans. DDW 2012, 2012. e-Pub 2012.
Lin SH, Myles B, Wang L, Thall PF, Vaporciyan AA, Mehran RJ, Swisher SG, Lee JH, Bhutani MS, Mar DM, Ajani JA, Cox JD, Komaki R, Zhongxing L. Propensity matched analysis to compare outcomes of 3D conformal radiotherapy (3D-CRT) to Intensity Modulated Radiation Therapy (IMRT) in the treatment of esophageal cancer. ASCO, 2012. e-Pub 2012.
Suzuki A, Xiao L, Hayashi Y, Blum MA, Welsh JW, Lin SH, Lee JH, Bhutani MS, Maru DM, Hofstetter WL, Erasmus J, Ajani JA. Nomograms for Prognostication of Patients with Esophageal and Gastroesophageal Carcinoma Undergoing Definitive Chemoradiotherapy. ASCO 2012, 2012. e-Pub 2012.
Ajani JA, Correa A, Hofstetter WL, Vaporciyan AA, Rice DC, Walsh GL, Mehran RJ, Suzuki A, Lee JH, Bhutani M, Lin SH, Welsh J, Maru DM, Swisher SG. The association between body mass index and baseline clinical stage of esophageal carcinoma. ASCO Annual Meeting 2011, 2011. e-Pub 2011.
Lee JH. Prognostic significance of post-treatment standardized uptake value (pSUV) of positron emission tomography (PET) to predict overall survival (OS) and relapse free survival (RFS) in patients with esophageal or gastroesophageal cancer treated with definitive chemoradiotherapy. ASCO Annual Meeting 2011, 2011. e-Pub 2011.
Suzuki A, Lianchun X, Hayashi Y, Welsh J, Lin SH, Lee JH, Bhutani M, Hofstetter W, Mehran RJ, Ajani JA. Value of the primary tumor initial standardized uptake value (iSUV) of 18F-fluorodeoxyglucose positron emission tomography (PET) to predict overall survival (OS) in patients with esophageal or gastroesophageal junction carcinoma undergoing definitive chemoradiotherapy. ASCO GI Symposium 2011, 2011. e-Pub 2011.
Singh A, Ross WA, Atiq M, Davila M, Raju GS, Bhutani MS, Lee JE, Fleming JB, Weston BR, Lee JH. Outcomes of Duodenal Stent vs. Gastrojejunostomy in Patient with Malignant Gastric Outlet Obstruction - report from tertiary cancer center. ACG 2011, 2011. e-Pub 2011.
Ajani JA, Wang X, Hayashi Y, Maru D, Welsh J, Hofstetter WL, Lee JH, Bhutani M, Berry D, Izzo J. Validated Biomarker Signatures that Predict Pathologic Response to Preoperative Chemoradiation Therapy (CTRT) with High Specificity and Desirable Sensitivity Levels in Patients with Esophageal Cancer (EC), 2011. e-Pub 2011.
Atiq M, Kulkarni P, Ross WA, Bhutani M, Lee JH. Diagnostic Utility of EUS-FNA for suspected pancreatic malignancy excluding obvious cystic lesions on CT imaging, MD Anderson Cancer Center experience. Society of Gastrointestinal Intervention, 2010. e-Pub 2010.
Lee, JH. Endoscopic treatment for biliary leaks and strictures. Society of Gastrointestinal Intervention, 2010. e-Pub 2010.
Kim HN, Lee JH, Ross WA. Role of ERCP in evaluation of post-stem cell transplantation patients with hepatobiliary disease. ACG Annual Meeting/poster, 2010. e-Pub 2010.
Jaganmohan S, Raju RP, Bhutani MS, Raju GS, Stroehlein JR, Lee JH. Risk of pancreatic cancer development in cancer survivors in the United States-a population-based epidemiological study using the seer database. DDW 2010/poster, 2010. e-Pub 2010.
Lee JH, Dasari CS, Harvinder S, Rashid A, Bhutani M, Raju RP, Jaganmohan S, Yao J, Alexandria P, Raju GS. Neuroendocrine tumors of the gastrointestinal tract and pancreas: diagnostic modalities, accuracy, and outcomes. DDW 2010/poster, 2010. e-Pub 2010.
Raju RP, Jaganmohan S, Bektas M, Bhutani MS, Lee JH. Prognostic implications of high-grade malignant esophageal strictures in esophageal cancer. DDW 2010/poster, 2010. e-Pub 2010.
Jaganmohan S, Raju RP, Ross WA, Javle M, Varadhachary GR, Raju GS, Abbruzzese J, Fleming JB, Stroehlein JR, Lee JH. Clear bile on ERCP for malignant biliary obstruction - incidental finding or an ominous sign? A comparative study. DDW 2010/ poster, 2010. e-Pub 2010.
Raju RP, Jaganmohan S, Ross WA, Stroehlein JR, Raju G, Wallace MJ, Javle M, Lee JH. Optimal Palliation of inoperable hilar cholangiocarcinoma: Comparative assessment of the efficacy of plastic and self-expandable metal stents. DDW 2010/poster, 2010. e-Pub 2010.
Singal A, Ross WA, Varadhachary GR, Javle M, Jaganmohan SR, Raju RP, Fleming J, Raju GS, Lee JH. Metal stents in surgically resectable pancreatic cancer: Single center experience on eighty three cases. ASGE/DDW 2010 poster, 2010. e-Pub 2010.
Canto MI, Schulick RD, Kamel IR, Fishman EK, Topazian MD, Takahashi N, Lee JH, Tamm EP, Vikram R, Syngal S, Saltzman JR, Mortele, KJ, Farrel JJ, Margolis D, Zhang Z, Petersen GM, Huban RH, Goggins MG. Screening for Familial Pancreatic Neoplasia: A Prospective, Multicenter Blinded Study of EUS, CT and Secretin-MRCP. Gastrointest Endosc 71(5):AB119, 2010. e-Pub 2010.
Kim MP, Hofstetter WL, Correa A, Marom EM, Maru DM, Macapinlac H, Lee JH, Rice DC, Roth JA, Walsh GL, Mehran RJ, Vaporciyan AA, Swisher SG. Pathologic T0N1 after neoadjuvant Therapy and Surgery for Esophageal Cancer: an Orphan Status. Society of Thoracic Surgeons 46th Annual Meeting:174-175, 2010. e-Pub 2010.
Wolf DS, Ross WA, Ajani JA, Hofstetter WL, Swisher SG, Rice D, Anandasabapathy S, Erasmus J, Lee JH. Diagnostic Accuracy of Endoscopic Ultrasound (EUS) and Management of T1 (T1 and T1b) Esophageal Cancer (EC). DDW, 2009. e-Pub 2009.
Hofstetter W, Correa A, Lee J, Shah N, Komaki R, Erasmus J, Maru D, Lee JH, Walsh G, Vaporciyan A, Rice D, Mehran R, Roth J, Ajani J, Swisher S. Salvage resection for esophageal adenocarcinoma after failed definitive chemoradiation. ASCO GI Meeting, Poster, 2009. e-Pub 2009.
Thatte R, Guha S, Lee JH, Ross WA. Epidemiology and endoscopic management of large colon polyps: Preliminary analysis of a cancer center experience. ACG, 2009. e-Pub 2009.
Fan X, Lee JH. EUS evaluation of HGD of esophagus is beneficial for patients with focal nodule or nodular mucosa. ACG, 2009. e-Pub 2009.
Bektas M, Ross WA, Lee JH, Bhutani MS. EUS FNA for diagnosis of cystic pancreatic neuroendocrine tumors: An important cause for pancreatic cysts. ACG, 2009. e-Pub 2009.
Bektas M, Lee JH, Guha S, Ross WA, Bhutani MS. Prevalence of extrapancreatic cysts in patients with cystic neoplasms of the pancreas. ACG, 2009. e-Pub 2009.
Lee JH, Dasari CS, Bhutani MS, Ross WA, Bektas M, Raju GS. Neuroendocrine Tumors of Gastrointestinal Tract and the Pancreas: Diagnostic Accuracy and Outcomes. ACG, 2009. e-Pub 2009.
Jaganmohan S, Varia A, Lee JH. Management of Duodenal lesions in Familial Adenomatous Polyposis (FAP). DDW/ASGE 2009 poster, 2009. e-Pub 2009.
Egwim CE, Wallace MJ, Wong M, Lee JH, Madoff DC, Ross WA. Outcomes in Lymphoma Patients with obstructive Jaundice. DDW 2009 Gastrointest Endosc, 2009. e-Pub 2009.
Shpaner A, Ross WA, Varadhachary G, Javle M, Evans DB, Fleming JB, Tamm EP, Lee JH. Endoscopic ultrasound (EUS) detection of pancreatic neoplasms in patients without definitive pancreatic mass on computed tomography (CT) scan. ASGE/DDW poster, 2009. e-Pub 2009.
Fan X, Lee JH, Sellin JH, Guha S. Prevalence of Barrett's esophagus in patients with esophageal adenocarcinoma and its association with cancer location and surveillance program. AGA/DDW poster, 2009. e-Pub 2009.
Swisher SG, Hofstetter W, Komaki R, Correa AM, Erasmus J, Liao Z, Lee JH, Maru D, Mehran R, Patel S, Phan A, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, and Ajani JA. Long-term Outcome of Sequential Phase II/III Trials with 5-FU Based Preoperative Chemo or Chemoradiotherapy Strategies in Locoregionally Advanced Esophageal Cancer. ASCO, 2009. e-Pub 2009.
Gaur P, Sepesi BA, Bhutani MS, Hofstetter W, Correa AM, Ajani JA, Erasmus J, Komaki R, Lee JH, Maru D, Mehran R, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Watson TJ, and Swisher SG. Endoscopic Esophageal Tumor Length (cL) Identifies Esophageal Cancer Patients with High Risk of Lymph Node Involvement and Poor Long-Term Survival: Internal and External Validation. American Surgical Association, 2009. e-Pub 2009.
Swisher SG, Hofstetter W, Komaki R, Correa AM, Erasmus J, Liao Z, Lee JH, Maru D, Mehran R, Patel S, Phan A, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Ajani JA. Sequential Phase II/III Trials with Preoperative Chemo or Chemoradiotherapy Strategies in Locoregionally Advanced Esophageal Cancer. American Surgical Association, 2009. e-Pub 2009.
Leung, KK, Ross W, Lin E, Lee JH. Diagnosis, antibiotic prophylaxis, and natural history of pancreatic cystic neoplasms: Is immediate surgery necessary?. ACG 2008, 2008. e-Pub 2008.
Weston BR, Iyer RB, Lee JH, Ross WA. Clinical Significance of Incidental 18F-FDG Uptake in the Colon on PET/CT: Colonoscopic findings in a case control study. DDW/ASGE 2008, 2008. e-Pub 2008.
Rice DC, Lee JH, Jimenez C, Eapen G, Stewart J, Hofstetter WL, Mehran R, Vaporciyan AA, Walsh GL, Swisher SG. Mediastinal Staging for Mesothelioma: Endoscopic Ultrasound or Mediastinoscopy?, 2008. e-Pub 2008.
Nasroulah F, Varadhachary GR, Abbruzzese JL, Crane C, Tamm EP, Lee JE, Wang H, Lee JH, Evans DE, Wolff RA. Serum CA19-9 is a prognostic but not a predictive marker in patients (pts) with resected pancreatic cancer (PC) undergoing preoperative (preop) chemoradiation(CT-RT), 2007. e-Pub 2007.
Settle, SH, Crane CH, Hodges JC, Das P, Varadhachary G, Tamm EP, Javle M, Lee JE, Fleming JB, Lee JH, Krishnan S, Evans DB, Wolff RA. Novel Use of Focal High-Dose IMRT for Borderline Resectable Pancreatic Cancer, 2007. e-Pub 2007.
Piesman M, Baron T, Lee JH, Edmundowicz S, Miqdadi J, Carr-Locke DL. A Prospective, Multi-Center Patency Study of the Luminexx. DDW poster, 2007. e-Pub 2007.
Goetz GH, Lee JH, Davila M, Fukami N, Ross WA. Performance of Covered vs Uncovered metal stents in malignant strictures of the common duct. DDW poster, 2007. e-Pub 2007.
Leung KK, Thirumurthi S, Ross WA, Lin E, and Lee JH. The Prognostic Value of Endoscopic Ultrasound Parameters, Serum Tumor Markers, Cyst Fluid Tumor Markers and Cyst Fluid Viscosity in Pancreatic Cyst Neoplasms. DDW poster, 2007. e-Pub 2007.
Lee JH. The Choice of Antibiotic Prophylaxis Prior to Endoscopic Ultrasound with Fine-Needle Aspiration of a Pancreatic Cyst. DDW poster, 2007. e-Pub 2007.
Lee JH, Stewart J, Anandasabapathy S, Thirumurthi S, Ross WA, Lin E, and Staerkel G. Comparison of performance of 22-gauge and 25-gauge needles in Endoscopic Ultrasound Guided Fine-needle aspiration. DDW poster, 2007. e-Pub 2007.
Weston BR, Ross WA, Lee JH. EUS-guided transesophageal FNA in the evaluation of non-esophageal cancer related mediastinal lesions. DDW poster, 2007. e-Pub 2007.
Nasroulah F, Varadhachary GR, Abbruzzese JL, Crane C, Tamm EP, Lee JE, Wang H, Lee JH, Evans DE, Wolff RA. Serum CA 19-9 is a prognostic but not a predictive marker in patients (pts) with resected pancreatic cancer (PC) undergoing preoperative (preop) chemoradiation (CT-RT). GI ASCO, 2007. e-Pub 2007.
Varadhachary GR, Wolff RA, Crane CH, Lee JE, Abdalla EK, Lee JH, Pisters PWT, Ho L, Abbruzzese JL, Evans DB. Preoperative gemcitabine (gem) and bevacizumab (bev) based chemoradiation for resectable pancreatic adenocarcinoma. GI ASCO, 2007. e-Pub 2007.
Weston BR, Ross WA, Lin E, Wang X, Lee JH. What happens to serum carbohydrate antigen 19-9 after biliary stent placement in pancreaticobiliary malignancy?. ACG poster, 2006. e-Pub 2006.
Lee JH. Endoscopic management of Barrett's with high-grade dysplasia and intramucosal cancer. ISGIO Conference podium presentation, 2006. e-Pub 2006.
Lee JH. Management of Esophageal Cancer and Barrett's Esophagus. 3rd Annual Official Meeting, Int'l Society of GI Oncology (ISGIO)-Arlington, VA, 2006. e-Pub 2006.
Goetz D, Lee JH, Fukami N, Davila ML, Ross WA. Complications following endoscopic stent placement for malignant biliary obstruction: preliminary analysis. DDW AGA poster, 2006. e-Pub 2006.
Ross WA, Dekovich AA, Cleary KR, Ghosh S, Lee JH, Couriel DR. Endoscopic diagnosis of early gastrointestinal graft-versus-host disease. DDW AGA podium presentation, 2006. e-Pub 2006.
Weston BR, Ross WA, Wang X, Xiao L, Wolff RA, Evans DB, Lee JH. Rate of bilirubin regression post biliary stent placement in malignant obstruction. DDW ASGE poster, 2006. e-Pub 2006.
Frank C, Ross WA, Prindiville T, Lee JH. Accuracy of EUS and PET staging of gastrointestinal cancers. DDW ASGE poster, 2006. e-Pub 2006.
Varadhachary G, Evans D, Crane CH, Xiong HQ, Lee JE, Pisters PW, Abdalla E, Tamm EP, Lee JH, Wolff RA. Interim results of preoperative gemcitabine (gem) plus cisplatin followed by rapid fractionation chemoradiation for resectable pancreatic adenocarcinoma. ASCO poster, 2006. e-Pub 2006.
Izzo JG, Wu TT, Luthra R, Malhotra U, Luthra M, Milas L, Liao Z, Swisher S, Lee JH, Bresalier RS, Hittelman WN, Aggarwal BB, Ajani JA. Activated Transcription Factor NF-kB is Associated with Chemo-Radiotherapy Resistance and Poor Outcome in Esophageal Adenocarcinoma. ASCO, Orlando, FL May, 2005. e-Pub 2005.
Malaisrie SC, Hofstetter WL, Correa AM, Ajani JA, Komaki RR, Liao Z, Phan A, Rice D, Vaporciyan AA, Walsh GL, Lahoti S, Lee JH, Bresalier R, Roth JA, Swisher SG. EUS-Identified Celiac Adenopathy Remains a Poor Prognostic Factor Despite Preoperative Chemoradiotherapy In Patients with Adenocarcinoma of the Distal Esophagus. Association of Thoracic Surgery, San Francisco, CA, Oral Presentation. April, 2005. e-Pub 2005.
Mullen JT, Gomez HF, Lee JH, Ross WA, Abdalla EK, J-N V, Lee JE, Pisters PWT, Evans DB. Pancreaticoduodenectomy Following Placement of Expandable Metal Stents. DDW (SSAT) Plenary session, Chicago, IL May, 2005. e-Pub 2005.
Wasan S, Lahoti S, Ross W, Staerkel G, Lee JH. EUS-guided FNA and ERCP in One Session in Presumed Malignant Biliary Obstruction. DDW Poster ASGE Section, May, 2005. e-Pub 2005.
Kalha I, Wasan SM, Staerkel G, Lahoti S, Lee JH. Utility of Endoscopic Ultrasound and Fine Needle Aspiration In Diagnosing Uncommon Pancreatic Tumors. ACG Plenary Session 268:AB582, 2004. e-Pub 2004.
Wasan SM, Evans D, Ross W, Lee JH. Metal Stents In Surgically Resectable Pancreatic Cancer. Oral Presentation, ACG Plenary Session 105:3, 2004. e-Pub 2004.
Lee JH, Raina D, Aslanian H, Chacho M, Topazian M. Complications Of Endoscopic Ultrasound and Fine Needle Aspiration of Pancreatic Cysts. DDW ASGE, 2003. e-Pub 2003.
Lee JH, Salem R, Aslanian H, Chacho M, Topazian M. Endoscopic Ultrasound and Fine Needle Aspiration. DDW ASGE, 2003. e-Pub 2003.
Sheehan S, Lee JH, Wells CK, Topazian M. Serum Amylase, Pancreatic Stenting, and Pancreatitis after Sphincter of Oddi Manometry. ACG, Oct, 2003. e-Pub 2003.
Aspelund G, Topazian MD, Lee JH, Andersen DK. Improved outcomes with limited pancreatic head resections for benign disease. SSAT, 2002. e-Pub 2002.
Lee JH, Johannes R, Van Dam J, Farraye F, Carr-Locke DL. How Best To Diagnose IPMT (Intraductal Papillary Mucinous Tumors). ASGE DDW, San Diego, May, 2000. e-Pub 2000.
Lee JH, Johannes R, Van Dam J, Taitelbaum G, Piper J, Carr-Locke DL. Argon Plasma Coagulation in Endoscopic Therapy. ASGE DDW, San Diego, May, 2000. e-Pub 2000.
Somnay K, Van Dam J, Lee JH, Shields S, Ruymann F, Carr-Locke DL. An Endoscopic Approach to Ampullary Adenomas. DDW Poster, Orlando Florida, May, 1999. e-Pub 1999.

Letters to the Editor

Litton JK, Lee JH, Arun BK. Reply to BRCA2-associated pancreatic cancer and current screening guidelines. Cancer 121: 3047, 2015.

Less

Selected Presentations & Talks

National Presentations

2024. Perforations: What is the management strategy?. Invited. DDW. Washington, DC, US.

Formal Peers

2018. Advanced endoscopy. San Diego, CA, US.

Less

CV information above last modified April 02, 2025

Jeffrey H Lee, MD, MPH

About Dr. Jeffrey H Lee

Present Title & Affiliation

Dual/Joint/Adjunct Appointment

Education & Training

Postgraduate Training

Experience & Service

Administrative Appointments/Responsibilities

Institutional Committee Activities

Honors & Awards

Professional Memberships

Selected Publications

Peer-Reviewed Articles

Other Articles

Editorials

Abstracts

Letters to the Editor

Selected Presentations & Talks

National Presentations

Formal Peers

Patient Reviews

Related Links

Care Centers and Clinics

Departments and Divisions

Labs

Help #EndCancer

Jeffrey H Lee, MD, MPH

About Dr. Jeffrey H Lee

Present Title & Affiliation

Dual/Joint/Adjunct Appointment

Education & Training

Postgraduate Training

Experience & Service

Administrative Appointments/Responsibilities

Institutional Committee Activities

Honors & Awards

Professional Memberships

Selected Publications

Peer-Reviewed Articles

Other Articles

Editorials

Abstracts

Letters to the Editor

Selected Presentations & Talks

National Presentations

Formal Peers

Patient Reviews

Request an Appointment

Related Links

Care Centers and Clinics

Departments and Divisions

Labs

Clinical Trials

Help #EndCancer

Give Now

Donate Blood

Volunteer